493434_Patient	hasGender	Female
493434_Patient	hasAgeCategory	Old
493434_Patient	hasStage	IV
493434_Patient	hasSmokingHabit	FormerSmoker
493434_Patient	hasBiomarker	EGFR_Positive
493434_Patient	hasRelapse_Progression	Progression
493434_Patient	patientDrug	Carboplatin
493434_Patient	patientDrug	Atezolizumab
493434_Patient	patientDrug	Paclitaxel
493434_Patient	patientDrug	Pemetrexed
493434_Patient	treatmentType	Intravenous_Chemotherapy
493434_Patient	treatmentType	Immunotherapy
493434_Patient	treatmentType	Radiotherapy_To_Bone
588015_Patient	hasGender	Female
588015_Patient	hasAgeCategory	Old
588015_Patient	hasStage	IV
588015_Patient	hasSmokingHabit	FormerSmoker
588015_Patient	hasBiomarker	EGFR_Positive
588015_Patient	hasBiomarker	ALK_Negative
588015_Patient	hasBiomarker	ROS1_Negative
588015_Patient	hasRelapse_Progression	Progression
588015_Patient	patientDrug	Carboplatin
588015_Patient	patientDrug	Atezolizumab
588015_Patient	patientDrug	Pemetrexed
588015_Patient	patientDrug	Cisplatin
588015_Patient	patientDrug	Vinorelbine
588015_Patient	treatmentType	Intravenous_Chemotherapy
588015_Patient	treatmentType	Immunotherapy
588015_Patient	treatmentType	Radiotherapy_To_Bone
588015_Patient	treatmentType	Surgery
751089_Patient	hasGender	Male
751089_Patient	hasAgeCategory	Old
751089_Patient	hasStage	IV
751089_Patient	hasSmokingHabit	FormerSmoker
751089_Patient	hasBiomarker	EGFR_Positive
751089_Patient	hasBiomarker	ALK_Negative
751089_Patient	hasRelapse_Progression	Progression
751089_Patient	patientDrug	Pemetrexed
751089_Patient	patientDrug	Cisplatin
751089_Patient	patientDrug	Docetaxel
751089_Patient	patientDrug	Daratumumab
751089_Patient	patientDrug	Nintedanib
751089_Patient	treatmentType	Intravenous_Chemotherapy
751089_Patient	treatmentType	Immunotherapy
2462990_Patient	hasGender	Female
2462990_Patient	hasAgeCategory	Old
2462990_Patient	hasStage	IV
2462990_Patient	hasSmokingHabit	CurrentSmoker
2462990_Patient	hasBiomarker	PDL1_Positive
2462990_Patient	hasBiomarker	ALK_Negative
2462990_Patient	hasBiomarker	BRAF_Negative
2462990_Patient	hasBiomarker	EGFR_Negative
2462990_Patient	hasRelapse_Progression	Progression
2462990_Patient	patientDrug	Carboplatin
2462990_Patient	patientDrug	Pemetrexed
2462990_Patient	patientDrug	Pembrolizumab
2462990_Patient	treatmentType	Intravenous_Chemotherapy
2462990_Patient	treatmentType	Immunotherapy
2462990_Patient	treatmentType	Radiotherapy_To_Bone
2462990_Patient	treatmentType	Thoracoscopy
2807165_Patient	hasGender	Female
2807165_Patient	hasAgeCategory	Young
2807165_Patient	hasStage	IV
2807165_Patient	hasSmokingHabit	FormerSmoker
2807165_Patient	hasBiomarker	EGFR_Negative
2807165_Patient	hasBiomarker	ROS1_Negative
2807165_Patient	hasRelapse_Progression	Progression
2807165_Patient	patientDrug	Pemetrexed
2807165_Patient	patientDrug	Cisplatin
2807165_Patient	patientDrug	Placebo%20Controlled%20Study
2807165_Patient	patientDrug	Pembrolizumab
2807165_Patient	patientDrug	Alectinib
2807165_Patient	patientDrug	Brigatinib
2807165_Patient	patientDrug	Lorlatinib
2807165_Patient	treatmentType	Molecular_Targeted_Therapy
2807165_Patient	treatmentType	Immunotherapy
2807165_Patient	treatmentType	Whole_Brain_Radiation_Therapy
1258242_Patient	hasGender	Female
1258242_Patient	hasAgeCategory	Young
1258242_Patient	hasStage	IV
1258242_Patient	hasSmokingHabit	FormerSmoker
1258242_Patient	hasBiomarker	EGFR_Positive
1258242_Patient	hasRelapse_Progression	Progression
1258242_Patient	patientDrug	Erlotinib
1258242_Patient	patientDrug	Emibetuzumab
1258242_Patient	treatmentType	Molecular_Targeted_Therapy
1258242_Patient	treatmentType	Immunotherapy
1258242_Patient	treatmentType	Whole_Brain_Radiation_Therapy
1258242_Patient	treatmentType	Radiotherapy_To_Bone
2603790_Patient	hasGender	Male
2603790_Patient	hasAgeCategory	Young
2603790_Patient	hasStage	IV
2603790_Patient	hasSmokingHabit	CurrentSmoker
2603790_Patient	hasBiomarker	EGFR_Positive
2603790_Patient	hasRelapse_Progression	Progression
2603790_Patient	patientDrug	Cisplatin
2603790_Patient	patientDrug	Gemcitabine
2603790_Patient	patientDrug	Durvalumab
2603790_Patient	treatmentType	Intravenous_Chemotherapy
2603790_Patient	treatmentType	Immunotherapy
2845808_Patient	hasGender	Male
2845808_Patient	hasAgeCategory	Old
2845808_Patient	hasStage	IV
2845808_Patient	hasSmokingHabit	CurrentSmoker
2845808_Patient	hasBiomarker	EGFR_Positive
2845808_Patient	hasRelapse_Progression	Progression
2845808_Patient	patientDrug	Carboplatin
2845808_Patient	patientDrug	Atezolizumab
2845808_Patient	patientDrug	Paclitaxel
2845808_Patient	patientDrug	Gemcitabine
2845808_Patient	treatmentType	Intravenous_Chemotherapy
2845808_Patient	treatmentType	Immunotherapy
2845808_Patient	treatmentType	Radiotherapy_To_Lung
1042707_Patient	hasGender	Male
1042707_Patient	hasAgeCategory	Old
1042707_Patient	hasStage	IIIA
1042707_Patient	hasSmokingHabit	CurrentSmoker
1042707_Patient	hasBiomarker	ALK_Negative
1042707_Patient	hasBiomarker	BRAF_Negative
1042707_Patient	hasBiomarker	EGFR_Negative
1042707_Patient	hasBiomarker	ROS1_Negative
1042707_Patient	hasRelapse_Progression	No_Progression
1042707_Patient	patientDrug	Carboplatin
1042707_Patient	patientDrug	Paclitaxel
1042707_Patient	patientDrug	Vinorelbine
1042707_Patient	patientDrug	Durvalumab
1042707_Patient	treatmentType	Intravenous_Chemotherapy
1042707_Patient	treatmentType	Concurrent_Chemoradiotherapy
1042707_Patient	treatmentType	Immunotherapy
1042707_Patient	treatmentType	Radiotherapy_To_Lung
1267046_Patient	hasGender	Female
1267046_Patient	hasAgeCategory	Old
1267046_Patient	hasStage	IVB
1267046_Patient	hasSmokingHabit	CurrentSmoker
1267046_Patient	hasBiomarker	PDL1_Positive
1267046_Patient	hasBiomarker	ALK_Negative
1267046_Patient	hasBiomarker	EGFR_Negative
1267046_Patient	hasBiomarker	ROS1_Negative
1267046_Patient	hasRelapse_Progression	Progression
1267046_Patient	patientDrug	Carboplatin
1267046_Patient	patientDrug	Pemetrexed
1267046_Patient	patientDrug	Other
1267046_Patient	patientDrug	Pembrolizumab
1267046_Patient	treatmentType	Intravenous_Chemotherapy
1267046_Patient	treatmentType	Immunotherapy
1267046_Patient	treatmentType	Radiotherapy_To_Bone
2325330_Patient	hasGender	Male
2325330_Patient	hasAgeCategory	Young
2325330_Patient	hasStage	IVA
2325330_Patient	hasSmokingHabit	CurrentSmoker
2325330_Patient	hasBiomarker	PDL1_Positive
2325330_Patient	hasBiomarker	ALK_Negative
2325330_Patient	hasBiomarker	BRAF_Negative
2325330_Patient	hasBiomarker	EGFR_Negative
2325330_Patient	hasBiomarker	ROS1_Negative
2325330_Patient	hasRelapse_Progression	Progression
2325330_Patient	patientDrug	Carboplatin
2325330_Patient	patientDrug	Paclitaxel
2325330_Patient	patientDrug	Pembrolizumab
2325330_Patient	treatmentType	Intravenous_Chemotherapy
2325330_Patient	treatmentType	Immunotherapy
2325330_Patient	treatmentType	Radiotherapy_To_Bone
2369878_Patient	hasGender	Male
2369878_Patient	hasAgeCategory	Young
2369878_Patient	hasStage	IIIB
2369878_Patient	hasSmokingHabit	NonSmoker
2369878_Patient	hasBiomarker	ALK_Positive
2369878_Patient	hasBiomarker	EGFR_Negative
2369878_Patient	hasRelapse_Progression	Progression
2369878_Patient	patientDrug	Cisplatin
2369878_Patient	patientDrug	Vinorelbine
2369878_Patient	patientDrug	Pembrolizumab
2369878_Patient	patientDrug	Crizotinib
2369878_Patient	treatmentType	Intravenous_Chemotherapy
2369878_Patient	treatmentType	Molecular_Targeted_Therapy
2369878_Patient	treatmentType	Immunotherapy
2670938_Patient	hasGender	Male
2670938_Patient	hasAgeCategory	Old
2670938_Patient	hasStage	IIA
2670938_Patient	hasSmokingHabit	CurrentSmoker
2670938_Patient	hasBiomarker	ALK_Negative
2670938_Patient	hasBiomarker	EGFR_Negative
2670938_Patient	hasRelapse_Progression	Progression
2670938_Patient	patientDrug	Carboplatin
2670938_Patient	patientDrug	Paclitaxel
2670938_Patient	patientDrug	Cisplatin
2670938_Patient	patientDrug	Vinorelbine
2670938_Patient	patientDrug	Pembrolizumab
2670938_Patient	patientDrug	Docetaxel
2670938_Patient	treatmentType	Intravenous_Chemotherapy
2670938_Patient	treatmentType	Immunotherapy
2670938_Patient	treatmentType	Neoadjuvant_Chemotherapy
2670938_Patient	treatmentType	Whole_Brain_Radiation_Therapy
2670938_Patient	treatmentType	Thoracoscopy
2777040_Patient	hasGender	Female
2777040_Patient	hasAgeCategory	Young
2777040_Patient	hasStage	IVB
2777040_Patient	hasSmokingHabit	CurrentSmoker
2777040_Patient	hasBiomarker	PDL1_Positive
2777040_Patient	hasBiomarker	ALK_Negative
2777040_Patient	hasBiomarker	EGFR_Negative
2777040_Patient	hasBiomarker	ROS1_Negative
2777040_Patient	hasRelapse_Progression	Progression
2777040_Patient	patientDrug	Carboplatin
2777040_Patient	patientDrug	Pemetrexed
2777040_Patient	patientDrug	Pembrolizumab
2777040_Patient	treatmentType	Intravenous_Chemotherapy
2777040_Patient	treatmentType	Immunotherapy
2777040_Patient	treatmentType	Whole_Brain_Radiation_Therapy
2803612_Patient	hasGender	Male
2803612_Patient	hasAgeCategory	Old
2803612_Patient	hasStage	IVA
2803612_Patient	hasSmokingHabit	CurrentSmoker
2803612_Patient	hasBiomarker	PDL1_Positive
2803612_Patient	hasBiomarker	ALK_Negative
2803612_Patient	hasBiomarker	EGFR_Negative
2803612_Patient	hasBiomarker	ROS1_Negative
2803612_Patient	hasRelapse_Progression	Progression
2803612_Patient	hasRelapse_Progression	Relapse
2803612_Patient	patientDrug	Paclitaxel
2803612_Patient	patientDrug	Pemetrexed
2803612_Patient	patientDrug	Cisplatin
2803612_Patient	patientDrug	Pembrolizumab
2803612_Patient	treatmentType	Intravenous_Chemotherapy
2803612_Patient	treatmentType	Concurrent_Chemoradiotherapy
2803612_Patient	treatmentType	Immunotherapy
2803612_Patient	treatmentType	Radiotherapy_To_Lung
2825213_Patient	hasGender	Female
2825213_Patient	hasAgeCategory	Young
2825213_Patient	hasStage	IVB
2825213_Patient	hasSmokingHabit	FormerSmoker
2825213_Patient	hasBiomarker	PDL1_Positive
2825213_Patient	hasBiomarker	ALK_Negative
2825213_Patient	hasBiomarker	EGFR_Negative
2825213_Patient	hasBiomarker	ROS1_Negative
2825213_Patient	hasRelapse_Progression	Progression
2825213_Patient	patientDrug	Carboplatin
2825213_Patient	patientDrug	Paclitaxel
2825213_Patient	patientDrug	Other
2825213_Patient	patientDrug	Pembrolizumab
2825213_Patient	patientDrug	Docetaxel
2825213_Patient	treatmentType	Intravenous_Chemotherapy
2825213_Patient	treatmentType	Immunotherapy
2825213_Patient	treatmentType	Whole_Brain_Radiation_Therapy
2825213_Patient	treatmentType	Open_Surgical_Procedure
2834441_Patient	hasGender	Male
2834441_Patient	hasAgeCategory	Young
2834441_Patient	hasStage	IVB
2834441_Patient	hasSmokingHabit	CurrentSmoker
2834441_Patient	hasBiomarker	PDL1_Positive
2834441_Patient	hasBiomarker	ALK_Negative
2834441_Patient	hasBiomarker	EGFR_Negative
2834441_Patient	hasBiomarker	KRAS_Negative
2834441_Patient	hasBiomarker	MET_Negative
2834441_Patient	hasBiomarker	RET_Negative
2834441_Patient	hasBiomarker	ROS1_Negative
2834441_Patient	hasRelapse_Progression	Progression
2834441_Patient	patientDrug	Atezolizumab
2834441_Patient	patientDrug	Pemetrexed
2834441_Patient	patientDrug	Cisplatin
2834441_Patient	patientDrug	Gemcitabine
2834441_Patient	patientDrug	Other
2834441_Patient	patientDrug	Docetaxel
2834441_Patient	patientDrug	Nintedanib
2834441_Patient	treatmentType	Intravenous_Chemotherapy
2834441_Patient	treatmentType	Immunotherapy
2834441_Patient	treatmentType	Whole_Brain_Radiation_Therapy
438540_Patient	hasGender	Male
438540_Patient	hasAgeCategory	Old
438540_Patient	hasStage	IVA
438540_Patient	hasSmokingHabit	FormerSmoker
438540_Patient	hasBiomarker	EGFR_Positive
438540_Patient	hasBiomarker	ALK_Negative
438540_Patient	hasBiomarker	PDL1_Negative
438540_Patient	hasBiomarker	ROS1_Negative
438540_Patient	hasRelapse_Progression	Progression
438540_Patient	patientDrug	Carboplatin
438540_Patient	patientDrug	Atezolizumab
438540_Patient	patientDrug	Pemetrexed
438540_Patient	treatmentType	Intravenous_Chemotherapy
438540_Patient	treatmentType	Immunotherapy
438540_Patient	treatmentType	Thoracoscopy
576411_Patient	hasGender	Female
576411_Patient	hasAgeCategory	Young
576411_Patient	hasStage	IIIB
576411_Patient	hasSmokingHabit	FormerSmoker
576411_Patient	hasBiomarker	EGFR_Positive
576411_Patient	hasRelapse_Progression	Progression
576411_Patient	patientDrug	Paclitaxel
576411_Patient	patientDrug	Pemetrexed
576411_Patient	patientDrug	Cisplatin
576411_Patient	patientDrug	Pembrolizumab
576411_Patient	treatmentType	Intravenous_Chemotherapy
576411_Patient	treatmentType	Concurrent_Chemoradiotherapy
576411_Patient	treatmentType	Immunotherapy
576411_Patient	treatmentType	Radiotherapy_To_Lung
583611_Patient	hasGender	Female
583611_Patient	hasAgeCategory	Old
583611_Patient	hasStage	IIIC
583611_Patient	hasSmokingHabit	CurrentSmoker
583611_Patient	hasBiomarker	EGFR_Positive
583611_Patient	hasBiomarker	PDL1_Positive
583611_Patient	hasBiomarker	ALK_Negative
583611_Patient	hasBiomarker	ROS1_Negative
583611_Patient	hasRelapse_Progression	No_Progression
583611_Patient	patientDrug	Carboplatin
583611_Patient	patientDrug	Vinorelbine
583611_Patient	patientDrug	Durvalumab
583611_Patient	treatmentType	Intravenous_Chemotherapy
583611_Patient	treatmentType	Concurrent_Chemoradiotherapy
583611_Patient	treatmentType	Immunotherapy
583611_Patient	treatmentType	Radiotherapy_To_Lung
619371_Patient	hasGender	Female
619371_Patient	hasAgeCategory	Young
619371_Patient	hasStage	IVB
619371_Patient	hasSmokingHabit	CurrentSmoker
619371_Patient	hasBiomarker	EGFR_Positive
619371_Patient	hasBiomarker	PDL1_Positive
619371_Patient	hasBiomarker	ALK_Negative
619371_Patient	hasBiomarker	ROS1_Negative
619371_Patient	hasRelapse_Progression	Progression
619371_Patient	patientDrug	Carboplatin
619371_Patient	patientDrug	Pemetrexed
619371_Patient	patientDrug	Pembrolizumab
619371_Patient	patientDrug	Docetaxel
619371_Patient	treatmentType	Intravenous_Chemotherapy
619371_Patient	treatmentType	Immunotherapy
619371_Patient	treatmentType	Radiotherapy_To_Lung
619371_Patient	treatmentType	Radiotherapy_To_Bone
623804_Patient	hasGender	Female
623804_Patient	hasAgeCategory	Young
623804_Patient	hasStage	IVB
623804_Patient	hasSmokingHabit	CurrentSmoker
623804_Patient	hasBiomarker	PDL1_Positive
623804_Patient	hasBiomarker	ALK_Negative
623804_Patient	hasBiomarker	EGFR_Negative
623804_Patient	hasBiomarker	ROS1_Negative
623804_Patient	hasRelapse_Progression	Progression
623804_Patient	patientDrug	Atezolizumab
623804_Patient	patientDrug	Pemetrexed
623804_Patient	patientDrug	Cisplatin
623804_Patient	patientDrug	Vinorelbine
623804_Patient	patientDrug	Docetaxel
623804_Patient	treatmentType	Intravenous_Chemotherapy
623804_Patient	treatmentType	Immunotherapy
623804_Patient	treatmentType	Whole_Brain_Radiation_Therapy
623804_Patient	treatmentType	Radiotherapy_To_Bone
810098_Patient	hasGender	Female
810098_Patient	hasAgeCategory	Young
810098_Patient	hasStage	IIIA
810098_Patient	hasSmokingHabit	FormerSmoker
810098_Patient	hasBiomarker	EGFR_Positive
810098_Patient	hasRelapse_Progression	Progression
810098_Patient	patientDrug	Carboplatin
810098_Patient	patientDrug	Atezolizumab
810098_Patient	patientDrug	Pemetrexed
810098_Patient	patientDrug	Vinorelbine
810098_Patient	patientDrug	Other
810098_Patient	patientDrug	Docetaxel
810098_Patient	treatmentType	Intravenous_Chemotherapy
810098_Patient	treatmentType	Chemotherapy_Adjuvant
810098_Patient	treatmentType	Molecular_Targeted_Therapy
810098_Patient	treatmentType	Concurrent_Chemoradiotherapy
810098_Patient	treatmentType	Immunotherapy
810098_Patient	treatmentType	Radiotherapy_To_Lung
810098_Patient	treatmentType	Whole_Brain_Radiation_Therapy
810098_Patient	treatmentType	Open_Surgical_Procedure
829640_Patient	hasGender	Female
829640_Patient	hasAgeCategory	Young
829640_Patient	hasStage	IVA
829640_Patient	hasSmokingHabit	CurrentSmoker
829640_Patient	hasBiomarker	EGFR_Positive
829640_Patient	hasBiomarker	PDL1_Positive
829640_Patient	hasBiomarker	ALK_Negative
829640_Patient	hasBiomarker	ROS1_Negative
829640_Patient	hasRelapse_Progression	Progression
829640_Patient	patientDrug	Carboplatin
829640_Patient	patientDrug	Pemetrexed
829640_Patient	patientDrug	Pembrolizumab
829640_Patient	patientDrug	Docetaxel
829640_Patient	treatmentType	Intravenous_Chemotherapy
829640_Patient	treatmentType	Immunotherapy
829640_Patient	treatmentType	Radiotherapy_To_Lung
790159_Patient	hasGender	Male
790159_Patient	hasAgeCategory	Old
790159_Patient	hasStage	IVA
790159_Patient	hasSmokingHabit	FormerSmoker
790159_Patient	hasBiomarker	PDL1_Positive
790159_Patient	hasRelapse_Progression	Progression
790159_Patient	patientDrug	Pembrolizumab
790159_Patient	patientDrug	Afatinib
790159_Patient	treatmentType	Immunotherapy
790159_Patient	treatmentType	Radiotherapy_To_Lung
1110078_Patient	hasGender	Male
1110078_Patient	hasAgeCategory	Young
1110078_Patient	hasStage	IVB
1110078_Patient	hasSmokingHabit	CurrentSmoker
1110078_Patient	hasBiomarker	EGFR_Positive
1110078_Patient	hasBiomarker	ALK_Negative
1110078_Patient	hasRelapse_Progression	Progression
1110078_Patient	patientDrug	Carboplatin
1110078_Patient	patientDrug	Paclitaxel
1110078_Patient	patientDrug	Pemetrexed
1110078_Patient	patientDrug	Cisplatin
1110078_Patient	patientDrug	Afatinib
1110078_Patient	patientDrug	Osimertinib
1110078_Patient	treatmentType	Intravenous_Chemotherapy
1110078_Patient	treatmentType	Molecular_Targeted_Therapy
1110078_Patient	treatmentType	Radiotherapy_To_Bone
2831180_Patient	hasGender	Female
2831180_Patient	hasAgeCategory	Young
2831180_Patient	hasStage	IVB
2831180_Patient	hasSmokingHabit	NonSmoker
2831180_Patient	hasBiomarker	EGFR_Positive
2831180_Patient	hasBiomarker	PDL1_Positive
2831180_Patient	hasBiomarker	ALK_Negative
2831180_Patient	hasBiomarker	ROS1_Negative
2831180_Patient	patientDrug	Afatinib
2831180_Patient	patientDrug	Osimertinib
2831180_Patient	treatmentType	Molecular_Targeted_Therapy
2831180_Patient	treatmentType	Radiotherapy_To_Bone
583557_Patient	hasGender	Male
583557_Patient	hasAgeCategory	Old
583557_Patient	hasStage	IVB
583557_Patient	hasSmokingHabit	NonSmoker
583557_Patient	hasBiomarker	EGFR_Positive
583557_Patient	hasBiomarker	ALK_Negative
583557_Patient	hasBiomarker	ROS1_Negative
583557_Patient	hasRelapse_Progression	Progression
583557_Patient	patientDrug	Carboplatin
583557_Patient	patientDrug	Pemetrexed
583557_Patient	patientDrug	Vinorelbine
583557_Patient	patientDrug	Erlotinib
583557_Patient	patientDrug	Gefitinib
583557_Patient	treatmentType	Molecular_Targeted_Therapy
583557_Patient	treatmentType	Immunotherapy
583557_Patient	treatmentType	Radiotherapy_To_Bone
1077426_Patient	hasGender	Female
1077426_Patient	hasAgeCategory	Young
1077426_Patient	hasStage	IVA
1077426_Patient	hasSmokingHabit	FormerSmoker
1077426_Patient	hasBiomarker	EGFR_Positive
1077426_Patient	hasBiomarker	PDL1_Positive
1077426_Patient	hasBiomarker	ALK_Negative
1077426_Patient	hasBiomarker	BRAF_Negative
1077426_Patient	hasBiomarker	ROS1_Negative
1077426_Patient	patientDrug	Osimertinib
1077426_Patient	treatmentType	Molecular_Targeted_Therapy
1077426_Patient	treatmentType	Whole_Brain_Radiation_Therapy
1077426_Patient	treatmentType	Radiotherapy_To_Bone
751089_Patient	patientDrug	Nivolumab
2462990_Patient	patientDrug	Nivolumab
2803612_Patient	patientDrug	Nivolumab
1267046_Patient	patientDrug	Nivolumab
2807165_Patient	patientDrug	Nivolumab
2670938_Patient	patientDrug	Nivolumab
493434_Patient	patientDrug	Nivolumab
1077426_Patient	hasBiomarker	EGFR_Negative
2825213_Patient	patientDrug	Nivolumab
2325330_Patient	patientDrug	Nivolumab
2777040_Patient	patientDrug	Nivolumab
1042707_Patient	patientDrug	Nivolumab
2369878_Patient	patientDrug	Nivolumab
2834441_Patient	patientDrug	Nivolumab
583557_Patient	hasBiomarker	EGFR_Negative
0493434_Patient	hasGender	Female
0493434_Patient	hasAgeCategory	Old
0493434_Patient	hasStage	IV
0493434_Patient	hasSmokingHabit	FormerSmoker
0493434_Patient	hasBiomarker	EGFR_Positive
0493434_Patient	hasRelapse_Progression	Progression
0493434_Patient	patientDrug	Carboplatin
0493434_Patient	patientDrug	Atezolizumab
0493434_Patient	patientDrug	Paclitaxel
0493434_Patient	patientDrug	Pemetrexed
0493434_Patient	treatmentType	Intravenous_Chemotherapy
0493434_Patient	treatmentType	Immunotherapy
0493434_Patient	treatmentType	Radiotherapy_To_Bone
0493434_Patient	patientDrug	Nivolumab
1493434_Patient	hasGender	Female
1493434_Patient	hasAgeCategory	Old
1493434_Patient	hasStage	IV
1493434_Patient	hasSmokingHabit	FormerSmoker
1493434_Patient	hasBiomarker	EGFR_Positive
1493434_Patient	hasRelapse_Progression	Progression
1493434_Patient	patientDrug	Carboplatin
1493434_Patient	patientDrug	Atezolizumab
1493434_Patient	patientDrug	Paclitaxel
1493434_Patient	patientDrug	Pemetrexed
1493434_Patient	treatmentType	Intravenous_Chemotherapy
1493434_Patient	treatmentType	Immunotherapy
1493434_Patient	treatmentType	Radiotherapy_To_Bone
1493434_Patient	patientDrug	Nivolumab
2493434_Patient	hasGender	Female
2493434_Patient	hasAgeCategory	Old
2493434_Patient	hasStage	IV
2493434_Patient	hasSmokingHabit	FormerSmoker
2493434_Patient	hasBiomarker	EGFR_Positive
2493434_Patient	hasRelapse_Progression	Progression
2493434_Patient	patientDrug	Carboplatin
2493434_Patient	patientDrug	Atezolizumab
2493434_Patient	patientDrug	Paclitaxel
2493434_Patient	patientDrug	Pemetrexed
2493434_Patient	treatmentType	Intravenous_Chemotherapy
2493434_Patient	treatmentType	Immunotherapy
2493434_Patient	treatmentType	Radiotherapy_To_Bone
2493434_Patient	patientDrug	Nivolumab
3493434_Patient	hasGender	Female
3493434_Patient	hasAgeCategory	Old
3493434_Patient	hasStage	IV
3493434_Patient	hasSmokingHabit	FormerSmoker
3493434_Patient	hasBiomarker	EGFR_Positive
3493434_Patient	hasRelapse_Progression	Progression
3493434_Patient	patientDrug	Carboplatin
3493434_Patient	patientDrug	Atezolizumab
3493434_Patient	patientDrug	Paclitaxel
3493434_Patient	patientDrug	Pemetrexed
3493434_Patient	treatmentType	Intravenous_Chemotherapy
3493434_Patient	treatmentType	Immunotherapy
3493434_Patient	treatmentType	Radiotherapy_To_Bone
3493434_Patient	patientDrug	Nivolumab
4493434_Patient	hasGender	Female
4493434_Patient	hasAgeCategory	Old
4493434_Patient	hasStage	IV
4493434_Patient	hasSmokingHabit	FormerSmoker
4493434_Patient	hasBiomarker	EGFR_Positive
4493434_Patient	hasRelapse_Progression	Progression
4493434_Patient	patientDrug	Carboplatin
4493434_Patient	patientDrug	Atezolizumab
4493434_Patient	patientDrug	Paclitaxel
4493434_Patient	patientDrug	Pemetrexed
4493434_Patient	treatmentType	Intravenous_Chemotherapy
4493434_Patient	treatmentType	Immunotherapy
4493434_Patient	treatmentType	Radiotherapy_To_Bone
4493434_Patient	patientDrug	Nivolumab
5493434_Patient	hasGender	Female
5493434_Patient	hasAgeCategory	Old
5493434_Patient	hasStage	IV
5493434_Patient	hasSmokingHabit	FormerSmoker
5493434_Patient	hasBiomarker	EGFR_Positive
5493434_Patient	hasRelapse_Progression	Progression
5493434_Patient	patientDrug	Carboplatin
5493434_Patient	patientDrug	Atezolizumab
5493434_Patient	patientDrug	Paclitaxel
5493434_Patient	patientDrug	Pemetrexed
5493434_Patient	treatmentType	Intravenous_Chemotherapy
5493434_Patient	treatmentType	Immunotherapy
5493434_Patient	treatmentType	Radiotherapy_To_Bone
5493434_Patient	patientDrug	Nivolumab
0588015_Patient	hasGender	Female
0588015_Patient	hasAgeCategory	Old
0588015_Patient	hasStage	IV
0588015_Patient	hasSmokingHabit	FormerSmoker
0588015_Patient	hasBiomarker	EGFR_Positive
0588015_Patient	hasBiomarker	ALK_Negative
0588015_Patient	hasBiomarker	ROS1_Negative
0588015_Patient	hasRelapse_Progression	Progression
0588015_Patient	patientDrug	Carboplatin
0588015_Patient	patientDrug	Atezolizumab
0588015_Patient	patientDrug	Pemetrexed
0588015_Patient	patientDrug	Cisplatin
0588015_Patient	patientDrug	Vinorelbine
0588015_Patient	treatmentType	Intravenous_Chemotherapy
0588015_Patient	treatmentType	Immunotherapy
0588015_Patient	treatmentType	Radiotherapy_To_Bone
0588015_Patient	treatmentType	Surgery
1588015_Patient	hasGender	Female
1588015_Patient	hasAgeCategory	Old
1588015_Patient	hasStage	IV
1588015_Patient	hasSmokingHabit	FormerSmoker
1588015_Patient	hasBiomarker	EGFR_Positive
1588015_Patient	hasBiomarker	ALK_Negative
1588015_Patient	hasBiomarker	ROS1_Negative
1588015_Patient	hasRelapse_Progression	Progression
1588015_Patient	patientDrug	Carboplatin
1588015_Patient	patientDrug	Atezolizumab
1588015_Patient	patientDrug	Pemetrexed
1588015_Patient	patientDrug	Cisplatin
1588015_Patient	patientDrug	Vinorelbine
1588015_Patient	treatmentType	Intravenous_Chemotherapy
1588015_Patient	treatmentType	Immunotherapy
1588015_Patient	treatmentType	Radiotherapy_To_Bone
1588015_Patient	treatmentType	Surgery
2588015_Patient	hasGender	Female
2588015_Patient	hasAgeCategory	Old
2588015_Patient	hasStage	IV
2588015_Patient	hasSmokingHabit	FormerSmoker
2588015_Patient	hasBiomarker	EGFR_Positive
2588015_Patient	hasBiomarker	ALK_Negative
2588015_Patient	hasBiomarker	ROS1_Negative
2588015_Patient	hasRelapse_Progression	Progression
2588015_Patient	patientDrug	Carboplatin
2588015_Patient	patientDrug	Atezolizumab
2588015_Patient	patientDrug	Pemetrexed
2588015_Patient	patientDrug	Cisplatin
2588015_Patient	patientDrug	Vinorelbine
2588015_Patient	treatmentType	Intravenous_Chemotherapy
2588015_Patient	treatmentType	Immunotherapy
2588015_Patient	treatmentType	Radiotherapy_To_Bone
2588015_Patient	treatmentType	Surgery
3588015_Patient	hasGender	Female
3588015_Patient	hasAgeCategory	Old
3588015_Patient	hasStage	IV
3588015_Patient	hasSmokingHabit	FormerSmoker
3588015_Patient	hasBiomarker	EGFR_Positive
3588015_Patient	hasBiomarker	ALK_Negative
3588015_Patient	hasBiomarker	ROS1_Negative
3588015_Patient	hasRelapse_Progression	Progression
3588015_Patient	patientDrug	Carboplatin
3588015_Patient	patientDrug	Atezolizumab
3588015_Patient	patientDrug	Pemetrexed
3588015_Patient	patientDrug	Cisplatin
3588015_Patient	patientDrug	Vinorelbine
3588015_Patient	treatmentType	Intravenous_Chemotherapy
3588015_Patient	treatmentType	Immunotherapy
3588015_Patient	treatmentType	Radiotherapy_To_Bone
3588015_Patient	treatmentType	Surgery
4588015_Patient	hasGender	Female
4588015_Patient	hasAgeCategory	Old
4588015_Patient	hasStage	IV
4588015_Patient	hasSmokingHabit	FormerSmoker
4588015_Patient	hasBiomarker	EGFR_Positive
4588015_Patient	hasBiomarker	ALK_Negative
4588015_Patient	hasBiomarker	ROS1_Negative
4588015_Patient	hasRelapse_Progression	Progression
4588015_Patient	patientDrug	Carboplatin
4588015_Patient	patientDrug	Atezolizumab
4588015_Patient	patientDrug	Pemetrexed
4588015_Patient	patientDrug	Cisplatin
4588015_Patient	patientDrug	Vinorelbine
4588015_Patient	treatmentType	Intravenous_Chemotherapy
4588015_Patient	treatmentType	Immunotherapy
4588015_Patient	treatmentType	Radiotherapy_To_Bone
4588015_Patient	treatmentType	Surgery
5588015_Patient	hasGender	Female
5588015_Patient	hasAgeCategory	Old
5588015_Patient	hasStage	IV
5588015_Patient	hasSmokingHabit	FormerSmoker
5588015_Patient	hasBiomarker	EGFR_Positive
5588015_Patient	hasBiomarker	ALK_Negative
5588015_Patient	hasBiomarker	ROS1_Negative
5588015_Patient	hasRelapse_Progression	Progression
5588015_Patient	patientDrug	Carboplatin
5588015_Patient	patientDrug	Atezolizumab
5588015_Patient	patientDrug	Pemetrexed
5588015_Patient	patientDrug	Cisplatin
5588015_Patient	patientDrug	Vinorelbine
5588015_Patient	treatmentType	Intravenous_Chemotherapy
5588015_Patient	treatmentType	Immunotherapy
5588015_Patient	treatmentType	Radiotherapy_To_Bone
5588015_Patient	treatmentType	Surgery
0751089_Patient	hasGender	Male
0751089_Patient	hasAgeCategory	Old
0751089_Patient	hasStage	IV
0751089_Patient	hasSmokingHabit	FormerSmoker
0751089_Patient	hasBiomarker	EGFR_Positive
0751089_Patient	hasBiomarker	ALK_Negative
0751089_Patient	hasRelapse_Progression	Progression
0751089_Patient	patientDrug	Pemetrexed
0751089_Patient	patientDrug	Cisplatin
0751089_Patient	patientDrug	Docetaxel
0751089_Patient	patientDrug	Daratumumab
0751089_Patient	patientDrug	Nintedanib
0751089_Patient	treatmentType	Intravenous_Chemotherapy
0751089_Patient	treatmentType	Immunotherapy
0751089_Patient	patientDrug	Nivolumab
1751089_Patient	hasGender	Male
1751089_Patient	hasAgeCategory	Old
1751089_Patient	hasStage	IV
1751089_Patient	hasSmokingHabit	FormerSmoker
1751089_Patient	hasBiomarker	EGFR_Positive
1751089_Patient	hasBiomarker	ALK_Negative
1751089_Patient	hasRelapse_Progression	Progression
1751089_Patient	patientDrug	Pemetrexed
1751089_Patient	patientDrug	Cisplatin
1751089_Patient	patientDrug	Docetaxel
1751089_Patient	patientDrug	Daratumumab
1751089_Patient	patientDrug	Nintedanib
1751089_Patient	treatmentType	Intravenous_Chemotherapy
1751089_Patient	treatmentType	Immunotherapy
1751089_Patient	patientDrug	Nivolumab
2751089_Patient	hasGender	Male
2751089_Patient	hasAgeCategory	Old
2751089_Patient	hasStage	IV
2751089_Patient	hasSmokingHabit	FormerSmoker
2751089_Patient	hasBiomarker	EGFR_Positive
2751089_Patient	hasBiomarker	ALK_Negative
2751089_Patient	hasRelapse_Progression	Progression
2751089_Patient	patientDrug	Pemetrexed
2751089_Patient	patientDrug	Cisplatin
2751089_Patient	patientDrug	Docetaxel
2751089_Patient	patientDrug	Daratumumab
2751089_Patient	patientDrug	Nintedanib
2751089_Patient	treatmentType	Intravenous_Chemotherapy
2751089_Patient	treatmentType	Immunotherapy
2751089_Patient	patientDrug	Nivolumab
3751089_Patient	hasGender	Male
3751089_Patient	hasAgeCategory	Old
3751089_Patient	hasStage	IV
3751089_Patient	hasSmokingHabit	FormerSmoker
3751089_Patient	hasBiomarker	EGFR_Positive
3751089_Patient	hasBiomarker	ALK_Negative
3751089_Patient	hasRelapse_Progression	Progression
3751089_Patient	patientDrug	Pemetrexed
3751089_Patient	patientDrug	Cisplatin
3751089_Patient	patientDrug	Docetaxel
3751089_Patient	patientDrug	Daratumumab
3751089_Patient	patientDrug	Nintedanib
3751089_Patient	treatmentType	Intravenous_Chemotherapy
3751089_Patient	treatmentType	Immunotherapy
3751089_Patient	patientDrug	Nivolumab
4751089_Patient	hasGender	Male
4751089_Patient	hasAgeCategory	Old
4751089_Patient	hasStage	IV
4751089_Patient	hasSmokingHabit	FormerSmoker
4751089_Patient	hasBiomarker	EGFR_Positive
4751089_Patient	hasBiomarker	ALK_Negative
4751089_Patient	hasRelapse_Progression	Progression
4751089_Patient	patientDrug	Pemetrexed
4751089_Patient	patientDrug	Cisplatin
4751089_Patient	patientDrug	Docetaxel
4751089_Patient	patientDrug	Daratumumab
4751089_Patient	patientDrug	Nintedanib
4751089_Patient	treatmentType	Intravenous_Chemotherapy
4751089_Patient	treatmentType	Immunotherapy
4751089_Patient	patientDrug	Nivolumab
5751089_Patient	hasGender	Male
5751089_Patient	hasAgeCategory	Old
5751089_Patient	hasStage	IV
5751089_Patient	hasSmokingHabit	FormerSmoker
5751089_Patient	hasBiomarker	EGFR_Positive
5751089_Patient	hasBiomarker	ALK_Negative
5751089_Patient	hasRelapse_Progression	Progression
5751089_Patient	patientDrug	Pemetrexed
5751089_Patient	patientDrug	Cisplatin
5751089_Patient	patientDrug	Docetaxel
5751089_Patient	patientDrug	Daratumumab
5751089_Patient	patientDrug	Nintedanib
5751089_Patient	treatmentType	Intravenous_Chemotherapy
5751089_Patient	treatmentType	Immunotherapy
5751089_Patient	patientDrug	Nivolumab
02462990_Patient	hasGender	Female
02462990_Patient	hasAgeCategory	Old
02462990_Patient	hasStage	IV
02462990_Patient	hasSmokingHabit	CurrentSmoker
02462990_Patient	hasBiomarker	PDL1_Positive
02462990_Patient	hasBiomarker	ALK_Negative
02462990_Patient	hasBiomarker	BRAF_Negative
02462990_Patient	hasBiomarker	EGFR_Negative
02462990_Patient	hasRelapse_Progression	Progression
02462990_Patient	patientDrug	Carboplatin
02462990_Patient	patientDrug	Pemetrexed
02462990_Patient	patientDrug	Pembrolizumab
02462990_Patient	treatmentType	Intravenous_Chemotherapy
02462990_Patient	treatmentType	Immunotherapy
02462990_Patient	treatmentType	Radiotherapy_To_Bone
02462990_Patient	treatmentType	Thoracoscopy
02462990_Patient	patientDrug	Nivolumab
12462990_Patient	hasGender	Female
12462990_Patient	hasAgeCategory	Old
12462990_Patient	hasStage	IV
12462990_Patient	hasSmokingHabit	CurrentSmoker
12462990_Patient	hasBiomarker	PDL1_Positive
12462990_Patient	hasBiomarker	ALK_Negative
12462990_Patient	hasBiomarker	BRAF_Negative
12462990_Patient	hasBiomarker	EGFR_Negative
12462990_Patient	hasRelapse_Progression	Progression
12462990_Patient	patientDrug	Carboplatin
12462990_Patient	patientDrug	Pemetrexed
12462990_Patient	patientDrug	Pembrolizumab
12462990_Patient	treatmentType	Intravenous_Chemotherapy
12462990_Patient	treatmentType	Immunotherapy
12462990_Patient	treatmentType	Radiotherapy_To_Bone
12462990_Patient	treatmentType	Thoracoscopy
12462990_Patient	patientDrug	Nivolumab
22462990_Patient	hasGender	Female
22462990_Patient	hasAgeCategory	Old
22462990_Patient	hasStage	IV
22462990_Patient	hasSmokingHabit	CurrentSmoker
22462990_Patient	hasBiomarker	PDL1_Positive
22462990_Patient	hasBiomarker	ALK_Negative
22462990_Patient	hasBiomarker	BRAF_Negative
22462990_Patient	hasBiomarker	EGFR_Negative
22462990_Patient	hasRelapse_Progression	Progression
22462990_Patient	patientDrug	Carboplatin
22462990_Patient	patientDrug	Pemetrexed
22462990_Patient	patientDrug	Pembrolizumab
22462990_Patient	treatmentType	Intravenous_Chemotherapy
22462990_Patient	treatmentType	Immunotherapy
22462990_Patient	treatmentType	Radiotherapy_To_Bone
22462990_Patient	treatmentType	Thoracoscopy
22462990_Patient	patientDrug	Nivolumab
32462990_Patient	hasGender	Female
32462990_Patient	hasAgeCategory	Old
32462990_Patient	hasStage	IV
32462990_Patient	hasSmokingHabit	CurrentSmoker
32462990_Patient	hasBiomarker	PDL1_Positive
32462990_Patient	hasBiomarker	ALK_Negative
32462990_Patient	hasBiomarker	BRAF_Negative
32462990_Patient	hasBiomarker	EGFR_Negative
32462990_Patient	hasRelapse_Progression	Progression
32462990_Patient	patientDrug	Carboplatin
32462990_Patient	patientDrug	Pemetrexed
32462990_Patient	patientDrug	Pembrolizumab
32462990_Patient	treatmentType	Intravenous_Chemotherapy
32462990_Patient	treatmentType	Immunotherapy
32462990_Patient	treatmentType	Radiotherapy_To_Bone
32462990_Patient	treatmentType	Thoracoscopy
32462990_Patient	patientDrug	Nivolumab
42462990_Patient	hasGender	Female
42462990_Patient	hasAgeCategory	Old
42462990_Patient	hasStage	IV
42462990_Patient	hasSmokingHabit	CurrentSmoker
42462990_Patient	hasBiomarker	PDL1_Positive
42462990_Patient	hasBiomarker	ALK_Negative
42462990_Patient	hasBiomarker	BRAF_Negative
42462990_Patient	hasBiomarker	EGFR_Negative
42462990_Patient	hasRelapse_Progression	Progression
42462990_Patient	patientDrug	Carboplatin
42462990_Patient	patientDrug	Pemetrexed
42462990_Patient	patientDrug	Pembrolizumab
42462990_Patient	treatmentType	Intravenous_Chemotherapy
42462990_Patient	treatmentType	Immunotherapy
42462990_Patient	treatmentType	Radiotherapy_To_Bone
42462990_Patient	treatmentType	Thoracoscopy
42462990_Patient	patientDrug	Nivolumab
52462990_Patient	hasGender	Female
52462990_Patient	hasAgeCategory	Old
52462990_Patient	hasStage	IV
52462990_Patient	hasSmokingHabit	CurrentSmoker
52462990_Patient	hasBiomarker	PDL1_Positive
52462990_Patient	hasBiomarker	ALK_Negative
52462990_Patient	hasBiomarker	BRAF_Negative
52462990_Patient	hasBiomarker	EGFR_Negative
52462990_Patient	hasRelapse_Progression	Progression
52462990_Patient	patientDrug	Carboplatin
52462990_Patient	patientDrug	Pemetrexed
52462990_Patient	patientDrug	Pembrolizumab
52462990_Patient	treatmentType	Intravenous_Chemotherapy
52462990_Patient	treatmentType	Immunotherapy
52462990_Patient	treatmentType	Radiotherapy_To_Bone
52462990_Patient	treatmentType	Thoracoscopy
52462990_Patient	patientDrug	Nivolumab
02807165_Patient	hasGender	Female
02807165_Patient	hasAgeCategory	Young
02807165_Patient	hasStage	IV
02807165_Patient	hasSmokingHabit	FormerSmoker
02807165_Patient	hasBiomarker	EGFR_Negative
02807165_Patient	hasBiomarker	ROS1_Negative
02807165_Patient	hasRelapse_Progression	Progression
02807165_Patient	patientDrug	Pemetrexed
02807165_Patient	patientDrug	Cisplatin
02807165_Patient	patientDrug	Placebo%20Controlled%20Study
02807165_Patient	patientDrug	Pembrolizumab
02807165_Patient	patientDrug	Alectinib
02807165_Patient	patientDrug	Brigatinib
02807165_Patient	patientDrug	Lorlatinib
02807165_Patient	treatmentType	Molecular_Targeted_Therapy
02807165_Patient	treatmentType	Immunotherapy
02807165_Patient	treatmentType	Whole_Brain_Radiation_Therapy
02807165_Patient	patientDrug	Nivolumab
12807165_Patient	hasGender	Female
12807165_Patient	hasAgeCategory	Young
12807165_Patient	hasStage	IV
12807165_Patient	hasSmokingHabit	FormerSmoker
12807165_Patient	hasBiomarker	EGFR_Negative
12807165_Patient	hasBiomarker	ROS1_Negative
12807165_Patient	hasRelapse_Progression	Progression
12807165_Patient	patientDrug	Pemetrexed
12807165_Patient	patientDrug	Cisplatin
12807165_Patient	patientDrug	Placebo%20Controlled%20Study
12807165_Patient	patientDrug	Pembrolizumab
12807165_Patient	patientDrug	Alectinib
12807165_Patient	patientDrug	Brigatinib
12807165_Patient	patientDrug	Lorlatinib
12807165_Patient	treatmentType	Molecular_Targeted_Therapy
12807165_Patient	treatmentType	Immunotherapy
12807165_Patient	treatmentType	Whole_Brain_Radiation_Therapy
12807165_Patient	patientDrug	Nivolumab
22807165_Patient	hasGender	Female
22807165_Patient	hasAgeCategory	Young
22807165_Patient	hasStage	IV
22807165_Patient	hasSmokingHabit	FormerSmoker
22807165_Patient	hasBiomarker	EGFR_Negative
22807165_Patient	hasBiomarker	ROS1_Negative
22807165_Patient	hasRelapse_Progression	Progression
22807165_Patient	patientDrug	Pemetrexed
22807165_Patient	patientDrug	Cisplatin
22807165_Patient	patientDrug	Placebo%20Controlled%20Study
22807165_Patient	patientDrug	Pembrolizumab
22807165_Patient	patientDrug	Alectinib
22807165_Patient	patientDrug	Brigatinib
22807165_Patient	patientDrug	Lorlatinib
22807165_Patient	treatmentType	Molecular_Targeted_Therapy
22807165_Patient	treatmentType	Immunotherapy
22807165_Patient	treatmentType	Whole_Brain_Radiation_Therapy
22807165_Patient	patientDrug	Nivolumab
32807165_Patient	hasGender	Female
32807165_Patient	hasAgeCategory	Young
32807165_Patient	hasStage	IV
32807165_Patient	hasSmokingHabit	FormerSmoker
32807165_Patient	hasBiomarker	EGFR_Negative
32807165_Patient	hasBiomarker	ROS1_Negative
32807165_Patient	hasRelapse_Progression	Progression
32807165_Patient	patientDrug	Pemetrexed
32807165_Patient	patientDrug	Cisplatin
32807165_Patient	patientDrug	Placebo%20Controlled%20Study
32807165_Patient	patientDrug	Pembrolizumab
32807165_Patient	patientDrug	Alectinib
32807165_Patient	patientDrug	Brigatinib
32807165_Patient	patientDrug	Lorlatinib
32807165_Patient	treatmentType	Molecular_Targeted_Therapy
32807165_Patient	treatmentType	Immunotherapy
32807165_Patient	treatmentType	Whole_Brain_Radiation_Therapy
32807165_Patient	patientDrug	Nivolumab
42807165_Patient	hasGender	Female
42807165_Patient	hasAgeCategory	Young
42807165_Patient	hasStage	IV
42807165_Patient	hasSmokingHabit	FormerSmoker
42807165_Patient	hasBiomarker	EGFR_Negative
42807165_Patient	hasBiomarker	ROS1_Negative
42807165_Patient	hasRelapse_Progression	Progression
42807165_Patient	patientDrug	Pemetrexed
42807165_Patient	patientDrug	Cisplatin
42807165_Patient	patientDrug	Placebo%20Controlled%20Study
42807165_Patient	patientDrug	Pembrolizumab
42807165_Patient	patientDrug	Alectinib
42807165_Patient	patientDrug	Brigatinib
42807165_Patient	patientDrug	Lorlatinib
42807165_Patient	treatmentType	Molecular_Targeted_Therapy
42807165_Patient	treatmentType	Immunotherapy
42807165_Patient	treatmentType	Whole_Brain_Radiation_Therapy
42807165_Patient	patientDrug	Nivolumab
52807165_Patient	hasGender	Female
52807165_Patient	hasAgeCategory	Young
52807165_Patient	hasStage	IV
52807165_Patient	hasSmokingHabit	FormerSmoker
52807165_Patient	hasBiomarker	EGFR_Negative
52807165_Patient	hasBiomarker	ROS1_Negative
52807165_Patient	hasRelapse_Progression	Progression
52807165_Patient	patientDrug	Pemetrexed
52807165_Patient	patientDrug	Cisplatin
52807165_Patient	patientDrug	Placebo%20Controlled%20Study
52807165_Patient	patientDrug	Pembrolizumab
52807165_Patient	patientDrug	Alectinib
52807165_Patient	patientDrug	Brigatinib
52807165_Patient	patientDrug	Lorlatinib
52807165_Patient	treatmentType	Molecular_Targeted_Therapy
52807165_Patient	treatmentType	Immunotherapy
52807165_Patient	treatmentType	Whole_Brain_Radiation_Therapy
52807165_Patient	patientDrug	Nivolumab
01258242_Patient	hasGender	Female
01258242_Patient	hasAgeCategory	Young
01258242_Patient	hasStage	IV
01258242_Patient	hasSmokingHabit	FormerSmoker
01258242_Patient	hasBiomarker	EGFR_Positive
01258242_Patient	hasRelapse_Progression	Progression
01258242_Patient	patientDrug	Erlotinib
01258242_Patient	patientDrug	Emibetuzumab
01258242_Patient	treatmentType	Molecular_Targeted_Therapy
01258242_Patient	treatmentType	Immunotherapy
01258242_Patient	treatmentType	Whole_Brain_Radiation_Therapy
01258242_Patient	treatmentType	Radiotherapy_To_Bone
11258242_Patient	hasGender	Female
11258242_Patient	hasAgeCategory	Young
11258242_Patient	hasStage	IV
11258242_Patient	hasSmokingHabit	FormerSmoker
11258242_Patient	hasBiomarker	EGFR_Positive
11258242_Patient	hasRelapse_Progression	Progression
11258242_Patient	patientDrug	Erlotinib
11258242_Patient	patientDrug	Emibetuzumab
11258242_Patient	treatmentType	Molecular_Targeted_Therapy
11258242_Patient	treatmentType	Immunotherapy
11258242_Patient	treatmentType	Whole_Brain_Radiation_Therapy
11258242_Patient	treatmentType	Radiotherapy_To_Bone
21258242_Patient	hasGender	Female
21258242_Patient	hasAgeCategory	Young
21258242_Patient	hasStage	IV
21258242_Patient	hasSmokingHabit	FormerSmoker
21258242_Patient	hasBiomarker	EGFR_Positive
21258242_Patient	hasRelapse_Progression	Progression
21258242_Patient	patientDrug	Erlotinib
21258242_Patient	patientDrug	Emibetuzumab
21258242_Patient	treatmentType	Molecular_Targeted_Therapy
21258242_Patient	treatmentType	Immunotherapy
21258242_Patient	treatmentType	Whole_Brain_Radiation_Therapy
21258242_Patient	treatmentType	Radiotherapy_To_Bone
31258242_Patient	hasGender	Female
31258242_Patient	hasAgeCategory	Young
31258242_Patient	hasStage	IV
31258242_Patient	hasSmokingHabit	FormerSmoker
31258242_Patient	hasBiomarker	EGFR_Positive
31258242_Patient	hasRelapse_Progression	Progression
31258242_Patient	patientDrug	Erlotinib
31258242_Patient	patientDrug	Emibetuzumab
31258242_Patient	treatmentType	Molecular_Targeted_Therapy
31258242_Patient	treatmentType	Immunotherapy
31258242_Patient	treatmentType	Whole_Brain_Radiation_Therapy
31258242_Patient	treatmentType	Radiotherapy_To_Bone
41258242_Patient	hasGender	Female
41258242_Patient	hasAgeCategory	Young
41258242_Patient	hasStage	IV
41258242_Patient	hasSmokingHabit	FormerSmoker
41258242_Patient	hasBiomarker	EGFR_Positive
41258242_Patient	hasRelapse_Progression	Progression
41258242_Patient	patientDrug	Erlotinib
41258242_Patient	patientDrug	Emibetuzumab
41258242_Patient	treatmentType	Molecular_Targeted_Therapy
41258242_Patient	treatmentType	Immunotherapy
41258242_Patient	treatmentType	Whole_Brain_Radiation_Therapy
41258242_Patient	treatmentType	Radiotherapy_To_Bone
51258242_Patient	hasGender	Female
51258242_Patient	hasAgeCategory	Young
51258242_Patient	hasStage	IV
51258242_Patient	hasSmokingHabit	FormerSmoker
51258242_Patient	hasBiomarker	EGFR_Positive
51258242_Patient	hasRelapse_Progression	Progression
51258242_Patient	patientDrug	Erlotinib
51258242_Patient	patientDrug	Emibetuzumab
51258242_Patient	treatmentType	Molecular_Targeted_Therapy
51258242_Patient	treatmentType	Immunotherapy
51258242_Patient	treatmentType	Whole_Brain_Radiation_Therapy
51258242_Patient	treatmentType	Radiotherapy_To_Bone
02603790_Patient	hasGender	Male
02603790_Patient	hasAgeCategory	Young
02603790_Patient	hasStage	IV
02603790_Patient	hasSmokingHabit	CurrentSmoker
02603790_Patient	hasBiomarker	EGFR_Positive
02603790_Patient	hasRelapse_Progression	Progression
02603790_Patient	patientDrug	Cisplatin
02603790_Patient	patientDrug	Gemcitabine
02603790_Patient	patientDrug	Durvalumab
02603790_Patient	treatmentType	Intravenous_Chemotherapy
02603790_Patient	treatmentType	Immunotherapy
12603790_Patient	hasGender	Male
12603790_Patient	hasAgeCategory	Young
12603790_Patient	hasStage	IV
12603790_Patient	hasSmokingHabit	CurrentSmoker
12603790_Patient	hasBiomarker	EGFR_Positive
12603790_Patient	hasRelapse_Progression	Progression
12603790_Patient	patientDrug	Cisplatin
12603790_Patient	patientDrug	Gemcitabine
12603790_Patient	patientDrug	Durvalumab
12603790_Patient	treatmentType	Intravenous_Chemotherapy
12603790_Patient	treatmentType	Immunotherapy
22603790_Patient	hasGender	Male
22603790_Patient	hasAgeCategory	Young
22603790_Patient	hasStage	IV
22603790_Patient	hasSmokingHabit	CurrentSmoker
22603790_Patient	hasBiomarker	EGFR_Positive
22603790_Patient	hasRelapse_Progression	Progression
22603790_Patient	patientDrug	Cisplatin
22603790_Patient	patientDrug	Gemcitabine
22603790_Patient	patientDrug	Durvalumab
22603790_Patient	treatmentType	Intravenous_Chemotherapy
22603790_Patient	treatmentType	Immunotherapy
32603790_Patient	hasGender	Male
32603790_Patient	hasAgeCategory	Young
32603790_Patient	hasStage	IV
32603790_Patient	hasSmokingHabit	CurrentSmoker
32603790_Patient	hasBiomarker	EGFR_Positive
32603790_Patient	hasRelapse_Progression	Progression
32603790_Patient	patientDrug	Cisplatin
32603790_Patient	patientDrug	Gemcitabine
32603790_Patient	patientDrug	Durvalumab
32603790_Patient	treatmentType	Intravenous_Chemotherapy
32603790_Patient	treatmentType	Immunotherapy
42603790_Patient	hasGender	Male
42603790_Patient	hasAgeCategory	Young
42603790_Patient	hasStage	IV
42603790_Patient	hasSmokingHabit	CurrentSmoker
42603790_Patient	hasBiomarker	EGFR_Positive
42603790_Patient	hasRelapse_Progression	Progression
42603790_Patient	patientDrug	Cisplatin
42603790_Patient	patientDrug	Gemcitabine
42603790_Patient	patientDrug	Durvalumab
42603790_Patient	treatmentType	Intravenous_Chemotherapy
42603790_Patient	treatmentType	Immunotherapy
52603790_Patient	hasGender	Male
52603790_Patient	hasAgeCategory	Young
52603790_Patient	hasStage	IV
52603790_Patient	hasSmokingHabit	CurrentSmoker
52603790_Patient	hasBiomarker	EGFR_Positive
52603790_Patient	hasRelapse_Progression	Progression
52603790_Patient	patientDrug	Cisplatin
52603790_Patient	patientDrug	Gemcitabine
52603790_Patient	patientDrug	Durvalumab
52603790_Patient	treatmentType	Intravenous_Chemotherapy
52603790_Patient	treatmentType	Immunotherapy
02845808_Patient	hasGender	Male
02845808_Patient	hasAgeCategory	Old
02845808_Patient	hasStage	IV
02845808_Patient	hasSmokingHabit	CurrentSmoker
02845808_Patient	hasBiomarker	EGFR_Positive
02845808_Patient	hasRelapse_Progression	Progression
02845808_Patient	patientDrug	Carboplatin
02845808_Patient	patientDrug	Atezolizumab
02845808_Patient	patientDrug	Paclitaxel
02845808_Patient	patientDrug	Gemcitabine
02845808_Patient	treatmentType	Intravenous_Chemotherapy
02845808_Patient	treatmentType	Immunotherapy
02845808_Patient	treatmentType	Radiotherapy_To_Lung
12845808_Patient	hasGender	Male
12845808_Patient	hasAgeCategory	Old
12845808_Patient	hasStage	IV
12845808_Patient	hasSmokingHabit	CurrentSmoker
12845808_Patient	hasBiomarker	EGFR_Positive
12845808_Patient	hasRelapse_Progression	Progression
12845808_Patient	patientDrug	Carboplatin
12845808_Patient	patientDrug	Atezolizumab
12845808_Patient	patientDrug	Paclitaxel
12845808_Patient	patientDrug	Gemcitabine
12845808_Patient	treatmentType	Intravenous_Chemotherapy
12845808_Patient	treatmentType	Immunotherapy
12845808_Patient	treatmentType	Radiotherapy_To_Lung
22845808_Patient	hasGender	Male
22845808_Patient	hasAgeCategory	Old
22845808_Patient	hasStage	IV
22845808_Patient	hasSmokingHabit	CurrentSmoker
22845808_Patient	hasBiomarker	EGFR_Positive
22845808_Patient	hasRelapse_Progression	Progression
22845808_Patient	patientDrug	Carboplatin
22845808_Patient	patientDrug	Atezolizumab
22845808_Patient	patientDrug	Paclitaxel
22845808_Patient	patientDrug	Gemcitabine
22845808_Patient	treatmentType	Intravenous_Chemotherapy
22845808_Patient	treatmentType	Immunotherapy
22845808_Patient	treatmentType	Radiotherapy_To_Lung
32845808_Patient	hasGender	Male
32845808_Patient	hasAgeCategory	Old
32845808_Patient	hasStage	IV
32845808_Patient	hasSmokingHabit	CurrentSmoker
32845808_Patient	hasBiomarker	EGFR_Positive
32845808_Patient	hasRelapse_Progression	Progression
32845808_Patient	patientDrug	Carboplatin
32845808_Patient	patientDrug	Atezolizumab
32845808_Patient	patientDrug	Paclitaxel
32845808_Patient	patientDrug	Gemcitabine
32845808_Patient	treatmentType	Intravenous_Chemotherapy
32845808_Patient	treatmentType	Immunotherapy
32845808_Patient	treatmentType	Radiotherapy_To_Lung
42845808_Patient	hasGender	Male
42845808_Patient	hasAgeCategory	Old
42845808_Patient	hasStage	IV
42845808_Patient	hasSmokingHabit	CurrentSmoker
42845808_Patient	hasBiomarker	EGFR_Positive
42845808_Patient	hasRelapse_Progression	Progression
42845808_Patient	patientDrug	Carboplatin
42845808_Patient	patientDrug	Atezolizumab
42845808_Patient	patientDrug	Paclitaxel
42845808_Patient	patientDrug	Gemcitabine
42845808_Patient	treatmentType	Intravenous_Chemotherapy
42845808_Patient	treatmentType	Immunotherapy
42845808_Patient	treatmentType	Radiotherapy_To_Lung
52845808_Patient	hasGender	Male
52845808_Patient	hasAgeCategory	Old
52845808_Patient	hasStage	IV
52845808_Patient	hasSmokingHabit	CurrentSmoker
52845808_Patient	hasBiomarker	EGFR_Positive
52845808_Patient	hasRelapse_Progression	Progression
52845808_Patient	patientDrug	Carboplatin
52845808_Patient	patientDrug	Atezolizumab
52845808_Patient	patientDrug	Paclitaxel
52845808_Patient	patientDrug	Gemcitabine
52845808_Patient	treatmentType	Intravenous_Chemotherapy
52845808_Patient	treatmentType	Immunotherapy
52845808_Patient	treatmentType	Radiotherapy_To_Lung
01042707_Patient	hasGender	Male
01042707_Patient	hasAgeCategory	Old
01042707_Patient	hasStage	IIIA
01042707_Patient	hasSmokingHabit	CurrentSmoker
01042707_Patient	hasBiomarker	ALK_Negative
01042707_Patient	hasBiomarker	BRAF_Negative
01042707_Patient	hasBiomarker	EGFR_Negative
01042707_Patient	hasBiomarker	ROS1_Negative
01042707_Patient	hasRelapse_Progression	No_Progression
01042707_Patient	patientDrug	Carboplatin
01042707_Patient	patientDrug	Paclitaxel
01042707_Patient	patientDrug	Vinorelbine
01042707_Patient	patientDrug	Durvalumab
01042707_Patient	treatmentType	Intravenous_Chemotherapy
01042707_Patient	treatmentType	Concurrent_Chemoradiotherapy
01042707_Patient	treatmentType	Immunotherapy
01042707_Patient	treatmentType	Radiotherapy_To_Lung
01042707_Patient	patientDrug	Nivolumab
11042707_Patient	hasGender	Male
11042707_Patient	hasAgeCategory	Old
11042707_Patient	hasStage	IIIA
11042707_Patient	hasSmokingHabit	CurrentSmoker
11042707_Patient	hasBiomarker	ALK_Negative
11042707_Patient	hasBiomarker	BRAF_Negative
11042707_Patient	hasBiomarker	EGFR_Negative
11042707_Patient	hasBiomarker	ROS1_Negative
11042707_Patient	hasRelapse_Progression	No_Progression
11042707_Patient	patientDrug	Carboplatin
11042707_Patient	patientDrug	Paclitaxel
11042707_Patient	patientDrug	Vinorelbine
11042707_Patient	patientDrug	Durvalumab
11042707_Patient	treatmentType	Intravenous_Chemotherapy
11042707_Patient	treatmentType	Concurrent_Chemoradiotherapy
11042707_Patient	treatmentType	Immunotherapy
11042707_Patient	treatmentType	Radiotherapy_To_Lung
11042707_Patient	patientDrug	Nivolumab
21042707_Patient	hasGender	Male
21042707_Patient	hasAgeCategory	Old
21042707_Patient	hasStage	IIIA
21042707_Patient	hasSmokingHabit	CurrentSmoker
21042707_Patient	hasBiomarker	ALK_Negative
21042707_Patient	hasBiomarker	BRAF_Negative
21042707_Patient	hasBiomarker	EGFR_Negative
21042707_Patient	hasBiomarker	ROS1_Negative
21042707_Patient	hasRelapse_Progression	No_Progression
21042707_Patient	patientDrug	Carboplatin
21042707_Patient	patientDrug	Paclitaxel
21042707_Patient	patientDrug	Vinorelbine
21042707_Patient	patientDrug	Durvalumab
21042707_Patient	treatmentType	Intravenous_Chemotherapy
21042707_Patient	treatmentType	Concurrent_Chemoradiotherapy
21042707_Patient	treatmentType	Immunotherapy
21042707_Patient	treatmentType	Radiotherapy_To_Lung
21042707_Patient	patientDrug	Nivolumab
31042707_Patient	hasGender	Male
31042707_Patient	hasAgeCategory	Old
31042707_Patient	hasStage	IIIA
31042707_Patient	hasSmokingHabit	CurrentSmoker
31042707_Patient	hasBiomarker	ALK_Negative
31042707_Patient	hasBiomarker	BRAF_Negative
31042707_Patient	hasBiomarker	EGFR_Negative
31042707_Patient	hasBiomarker	ROS1_Negative
31042707_Patient	hasRelapse_Progression	No_Progression
31042707_Patient	patientDrug	Carboplatin
31042707_Patient	patientDrug	Paclitaxel
31042707_Patient	patientDrug	Vinorelbine
31042707_Patient	patientDrug	Durvalumab
31042707_Patient	treatmentType	Intravenous_Chemotherapy
31042707_Patient	treatmentType	Concurrent_Chemoradiotherapy
31042707_Patient	treatmentType	Immunotherapy
31042707_Patient	treatmentType	Radiotherapy_To_Lung
31042707_Patient	patientDrug	Nivolumab
41042707_Patient	hasGender	Male
41042707_Patient	hasAgeCategory	Old
41042707_Patient	hasStage	IIIA
41042707_Patient	hasSmokingHabit	CurrentSmoker
41042707_Patient	hasBiomarker	ALK_Negative
41042707_Patient	hasBiomarker	BRAF_Negative
41042707_Patient	hasBiomarker	EGFR_Negative
41042707_Patient	hasBiomarker	ROS1_Negative
41042707_Patient	hasRelapse_Progression	No_Progression
41042707_Patient	patientDrug	Carboplatin
41042707_Patient	patientDrug	Paclitaxel
41042707_Patient	patientDrug	Vinorelbine
41042707_Patient	patientDrug	Durvalumab
41042707_Patient	treatmentType	Intravenous_Chemotherapy
41042707_Patient	treatmentType	Concurrent_Chemoradiotherapy
41042707_Patient	treatmentType	Immunotherapy
41042707_Patient	treatmentType	Radiotherapy_To_Lung
41042707_Patient	patientDrug	Nivolumab
51042707_Patient	hasGender	Male
51042707_Patient	hasAgeCategory	Old
51042707_Patient	hasStage	IIIA
51042707_Patient	hasSmokingHabit	CurrentSmoker
51042707_Patient	hasBiomarker	ALK_Negative
51042707_Patient	hasBiomarker	BRAF_Negative
51042707_Patient	hasBiomarker	EGFR_Negative
51042707_Patient	hasBiomarker	ROS1_Negative
51042707_Patient	hasRelapse_Progression	No_Progression
51042707_Patient	patientDrug	Carboplatin
51042707_Patient	patientDrug	Paclitaxel
51042707_Patient	patientDrug	Vinorelbine
51042707_Patient	patientDrug	Durvalumab
51042707_Patient	treatmentType	Intravenous_Chemotherapy
51042707_Patient	treatmentType	Concurrent_Chemoradiotherapy
51042707_Patient	treatmentType	Immunotherapy
51042707_Patient	treatmentType	Radiotherapy_To_Lung
51042707_Patient	patientDrug	Nivolumab
01267046_Patient	hasGender	Female
01267046_Patient	hasAgeCategory	Old
01267046_Patient	hasStage	IVB
01267046_Patient	hasSmokingHabit	CurrentSmoker
01267046_Patient	hasBiomarker	PDL1_Positive
01267046_Patient	hasBiomarker	ALK_Negative
01267046_Patient	hasBiomarker	EGFR_Negative
01267046_Patient	hasBiomarker	ROS1_Negative
01267046_Patient	hasRelapse_Progression	Progression
01267046_Patient	patientDrug	Carboplatin
01267046_Patient	patientDrug	Pemetrexed
01267046_Patient	patientDrug	Other
01267046_Patient	patientDrug	Pembrolizumab
01267046_Patient	treatmentType	Intravenous_Chemotherapy
01267046_Patient	treatmentType	Immunotherapy
01267046_Patient	treatmentType	Radiotherapy_To_Bone
01267046_Patient	patientDrug	Nivolumab
11267046_Patient	hasGender	Female
11267046_Patient	hasAgeCategory	Old
11267046_Patient	hasStage	IVB
11267046_Patient	hasSmokingHabit	CurrentSmoker
11267046_Patient	hasBiomarker	PDL1_Positive
11267046_Patient	hasBiomarker	ALK_Negative
11267046_Patient	hasBiomarker	EGFR_Negative
11267046_Patient	hasBiomarker	ROS1_Negative
11267046_Patient	hasRelapse_Progression	Progression
11267046_Patient	patientDrug	Carboplatin
11267046_Patient	patientDrug	Pemetrexed
11267046_Patient	patientDrug	Other
11267046_Patient	patientDrug	Pembrolizumab
11267046_Patient	treatmentType	Intravenous_Chemotherapy
11267046_Patient	treatmentType	Immunotherapy
11267046_Patient	treatmentType	Radiotherapy_To_Bone
11267046_Patient	patientDrug	Nivolumab
21267046_Patient	hasGender	Female
21267046_Patient	hasAgeCategory	Old
21267046_Patient	hasStage	IVB
21267046_Patient	hasSmokingHabit	CurrentSmoker
21267046_Patient	hasBiomarker	PDL1_Positive
21267046_Patient	hasBiomarker	ALK_Negative
21267046_Patient	hasBiomarker	EGFR_Negative
21267046_Patient	hasBiomarker	ROS1_Negative
21267046_Patient	hasRelapse_Progression	Progression
21267046_Patient	patientDrug	Carboplatin
21267046_Patient	patientDrug	Pemetrexed
21267046_Patient	patientDrug	Other
21267046_Patient	patientDrug	Pembrolizumab
21267046_Patient	treatmentType	Intravenous_Chemotherapy
21267046_Patient	treatmentType	Immunotherapy
21267046_Patient	treatmentType	Radiotherapy_To_Bone
21267046_Patient	patientDrug	Nivolumab
31267046_Patient	hasGender	Female
31267046_Patient	hasAgeCategory	Old
31267046_Patient	hasStage	IVB
31267046_Patient	hasSmokingHabit	CurrentSmoker
31267046_Patient	hasBiomarker	PDL1_Positive
31267046_Patient	hasBiomarker	ALK_Negative
31267046_Patient	hasBiomarker	EGFR_Negative
31267046_Patient	hasBiomarker	ROS1_Negative
31267046_Patient	hasRelapse_Progression	Progression
31267046_Patient	patientDrug	Carboplatin
31267046_Patient	patientDrug	Pemetrexed
31267046_Patient	patientDrug	Other
31267046_Patient	patientDrug	Pembrolizumab
31267046_Patient	treatmentType	Intravenous_Chemotherapy
31267046_Patient	treatmentType	Immunotherapy
31267046_Patient	treatmentType	Radiotherapy_To_Bone
31267046_Patient	patientDrug	Nivolumab
41267046_Patient	hasGender	Female
41267046_Patient	hasAgeCategory	Old
41267046_Patient	hasStage	IVB
41267046_Patient	hasSmokingHabit	CurrentSmoker
41267046_Patient	hasBiomarker	PDL1_Positive
41267046_Patient	hasBiomarker	ALK_Negative
41267046_Patient	hasBiomarker	EGFR_Negative
41267046_Patient	hasBiomarker	ROS1_Negative
41267046_Patient	hasRelapse_Progression	Progression
41267046_Patient	patientDrug	Carboplatin
41267046_Patient	patientDrug	Pemetrexed
41267046_Patient	patientDrug	Other
41267046_Patient	patientDrug	Pembrolizumab
41267046_Patient	treatmentType	Intravenous_Chemotherapy
41267046_Patient	treatmentType	Immunotherapy
41267046_Patient	treatmentType	Radiotherapy_To_Bone
41267046_Patient	patientDrug	Nivolumab
51267046_Patient	hasGender	Female
51267046_Patient	hasAgeCategory	Old
51267046_Patient	hasStage	IVB
51267046_Patient	hasSmokingHabit	CurrentSmoker
51267046_Patient	hasBiomarker	PDL1_Positive
51267046_Patient	hasBiomarker	ALK_Negative
51267046_Patient	hasBiomarker	EGFR_Negative
51267046_Patient	hasBiomarker	ROS1_Negative
51267046_Patient	hasRelapse_Progression	Progression
51267046_Patient	patientDrug	Carboplatin
51267046_Patient	patientDrug	Pemetrexed
51267046_Patient	patientDrug	Other
51267046_Patient	patientDrug	Pembrolizumab
51267046_Patient	treatmentType	Intravenous_Chemotherapy
51267046_Patient	treatmentType	Immunotherapy
51267046_Patient	treatmentType	Radiotherapy_To_Bone
51267046_Patient	patientDrug	Nivolumab
02325330_Patient	hasGender	Male
02325330_Patient	hasAgeCategory	Young
02325330_Patient	hasStage	IVA
02325330_Patient	hasSmokingHabit	CurrentSmoker
02325330_Patient	hasBiomarker	PDL1_Positive
02325330_Patient	hasBiomarker	ALK_Negative
02325330_Patient	hasBiomarker	BRAF_Negative
02325330_Patient	hasBiomarker	EGFR_Negative
02325330_Patient	hasBiomarker	ROS1_Negative
02325330_Patient	hasRelapse_Progression	Progression
02325330_Patient	patientDrug	Carboplatin
02325330_Patient	patientDrug	Paclitaxel
02325330_Patient	patientDrug	Pembrolizumab
02325330_Patient	treatmentType	Intravenous_Chemotherapy
02325330_Patient	treatmentType	Immunotherapy
02325330_Patient	treatmentType	Radiotherapy_To_Bone
02325330_Patient	patientDrug	Nivolumab
12325330_Patient	hasGender	Male
12325330_Patient	hasAgeCategory	Young
12325330_Patient	hasStage	IVA
12325330_Patient	hasSmokingHabit	CurrentSmoker
12325330_Patient	hasBiomarker	PDL1_Positive
12325330_Patient	hasBiomarker	ALK_Negative
12325330_Patient	hasBiomarker	BRAF_Negative
12325330_Patient	hasBiomarker	EGFR_Negative
12325330_Patient	hasBiomarker	ROS1_Negative
12325330_Patient	hasRelapse_Progression	Progression
12325330_Patient	patientDrug	Carboplatin
12325330_Patient	patientDrug	Paclitaxel
12325330_Patient	patientDrug	Pembrolizumab
12325330_Patient	treatmentType	Intravenous_Chemotherapy
12325330_Patient	treatmentType	Immunotherapy
12325330_Patient	treatmentType	Radiotherapy_To_Bone
12325330_Patient	patientDrug	Nivolumab
22325330_Patient	hasGender	Male
22325330_Patient	hasAgeCategory	Young
22325330_Patient	hasStage	IVA
22325330_Patient	hasSmokingHabit	CurrentSmoker
22325330_Patient	hasBiomarker	PDL1_Positive
22325330_Patient	hasBiomarker	ALK_Negative
22325330_Patient	hasBiomarker	BRAF_Negative
22325330_Patient	hasBiomarker	EGFR_Negative
22325330_Patient	hasBiomarker	ROS1_Negative
22325330_Patient	hasRelapse_Progression	Progression
22325330_Patient	patientDrug	Carboplatin
22325330_Patient	patientDrug	Paclitaxel
22325330_Patient	patientDrug	Pembrolizumab
22325330_Patient	treatmentType	Intravenous_Chemotherapy
22325330_Patient	treatmentType	Immunotherapy
22325330_Patient	treatmentType	Radiotherapy_To_Bone
22325330_Patient	patientDrug	Nivolumab
32325330_Patient	hasGender	Male
32325330_Patient	hasAgeCategory	Young
32325330_Patient	hasStage	IVA
32325330_Patient	hasSmokingHabit	CurrentSmoker
32325330_Patient	hasBiomarker	PDL1_Positive
32325330_Patient	hasBiomarker	ALK_Negative
32325330_Patient	hasBiomarker	BRAF_Negative
32325330_Patient	hasBiomarker	EGFR_Negative
32325330_Patient	hasBiomarker	ROS1_Negative
32325330_Patient	hasRelapse_Progression	Progression
32325330_Patient	patientDrug	Carboplatin
32325330_Patient	patientDrug	Paclitaxel
32325330_Patient	patientDrug	Pembrolizumab
32325330_Patient	treatmentType	Intravenous_Chemotherapy
32325330_Patient	treatmentType	Immunotherapy
32325330_Patient	treatmentType	Radiotherapy_To_Bone
32325330_Patient	patientDrug	Nivolumab
42325330_Patient	hasGender	Male
42325330_Patient	hasAgeCategory	Young
42325330_Patient	hasStage	IVA
42325330_Patient	hasSmokingHabit	CurrentSmoker
42325330_Patient	hasBiomarker	PDL1_Positive
42325330_Patient	hasBiomarker	ALK_Negative
42325330_Patient	hasBiomarker	BRAF_Negative
42325330_Patient	hasBiomarker	EGFR_Negative
42325330_Patient	hasBiomarker	ROS1_Negative
42325330_Patient	hasRelapse_Progression	Progression
42325330_Patient	patientDrug	Carboplatin
42325330_Patient	patientDrug	Paclitaxel
42325330_Patient	patientDrug	Pembrolizumab
42325330_Patient	treatmentType	Intravenous_Chemotherapy
42325330_Patient	treatmentType	Immunotherapy
42325330_Patient	treatmentType	Radiotherapy_To_Bone
42325330_Patient	patientDrug	Nivolumab
52325330_Patient	hasGender	Male
52325330_Patient	hasAgeCategory	Young
52325330_Patient	hasStage	IVA
52325330_Patient	hasSmokingHabit	CurrentSmoker
52325330_Patient	hasBiomarker	PDL1_Positive
52325330_Patient	hasBiomarker	ALK_Negative
52325330_Patient	hasBiomarker	BRAF_Negative
52325330_Patient	hasBiomarker	EGFR_Negative
52325330_Patient	hasBiomarker	ROS1_Negative
52325330_Patient	hasRelapse_Progression	Progression
52325330_Patient	patientDrug	Carboplatin
52325330_Patient	patientDrug	Paclitaxel
52325330_Patient	patientDrug	Pembrolizumab
52325330_Patient	treatmentType	Intravenous_Chemotherapy
52325330_Patient	treatmentType	Immunotherapy
52325330_Patient	treatmentType	Radiotherapy_To_Bone
52325330_Patient	patientDrug	Nivolumab
02369878_Patient	hasGender	Male
02369878_Patient	hasAgeCategory	Young
02369878_Patient	hasStage	IIIB
02369878_Patient	hasSmokingHabit	NonSmoker
02369878_Patient	hasBiomarker	ALK_Positive
02369878_Patient	hasBiomarker	EGFR_Negative
02369878_Patient	hasRelapse_Progression	Progression
02369878_Patient	patientDrug	Cisplatin
02369878_Patient	patientDrug	Vinorelbine
02369878_Patient	patientDrug	Pembrolizumab
02369878_Patient	patientDrug	Crizotinib
02369878_Patient	treatmentType	Intravenous_Chemotherapy
02369878_Patient	treatmentType	Molecular_Targeted_Therapy
02369878_Patient	treatmentType	Immunotherapy
02369878_Patient	patientDrug	Nivolumab
12369878_Patient	hasGender	Male
12369878_Patient	hasAgeCategory	Young
12369878_Patient	hasStage	IIIB
12369878_Patient	hasSmokingHabit	NonSmoker
12369878_Patient	hasBiomarker	ALK_Positive
12369878_Patient	hasBiomarker	EGFR_Negative
12369878_Patient	hasRelapse_Progression	Progression
12369878_Patient	patientDrug	Cisplatin
12369878_Patient	patientDrug	Vinorelbine
12369878_Patient	patientDrug	Pembrolizumab
12369878_Patient	patientDrug	Crizotinib
12369878_Patient	treatmentType	Intravenous_Chemotherapy
12369878_Patient	treatmentType	Molecular_Targeted_Therapy
12369878_Patient	treatmentType	Immunotherapy
12369878_Patient	patientDrug	Nivolumab
22369878_Patient	hasGender	Male
22369878_Patient	hasAgeCategory	Young
22369878_Patient	hasStage	IIIB
22369878_Patient	hasSmokingHabit	NonSmoker
22369878_Patient	hasBiomarker	ALK_Positive
22369878_Patient	hasBiomarker	EGFR_Negative
22369878_Patient	hasRelapse_Progression	Progression
22369878_Patient	patientDrug	Cisplatin
22369878_Patient	patientDrug	Vinorelbine
22369878_Patient	patientDrug	Pembrolizumab
22369878_Patient	patientDrug	Crizotinib
22369878_Patient	treatmentType	Intravenous_Chemotherapy
22369878_Patient	treatmentType	Molecular_Targeted_Therapy
22369878_Patient	treatmentType	Immunotherapy
22369878_Patient	patientDrug	Nivolumab
32369878_Patient	hasGender	Male
32369878_Patient	hasAgeCategory	Young
32369878_Patient	hasStage	IIIB
32369878_Patient	hasSmokingHabit	NonSmoker
32369878_Patient	hasBiomarker	ALK_Positive
32369878_Patient	hasBiomarker	EGFR_Negative
32369878_Patient	hasRelapse_Progression	Progression
32369878_Patient	patientDrug	Cisplatin
32369878_Patient	patientDrug	Vinorelbine
32369878_Patient	patientDrug	Pembrolizumab
32369878_Patient	patientDrug	Crizotinib
32369878_Patient	treatmentType	Intravenous_Chemotherapy
32369878_Patient	treatmentType	Molecular_Targeted_Therapy
32369878_Patient	treatmentType	Immunotherapy
32369878_Patient	patientDrug	Nivolumab
42369878_Patient	hasGender	Male
42369878_Patient	hasAgeCategory	Young
42369878_Patient	hasStage	IIIB
42369878_Patient	hasSmokingHabit	NonSmoker
42369878_Patient	hasBiomarker	ALK_Positive
42369878_Patient	hasBiomarker	EGFR_Negative
42369878_Patient	hasRelapse_Progression	Progression
42369878_Patient	patientDrug	Cisplatin
42369878_Patient	patientDrug	Vinorelbine
42369878_Patient	patientDrug	Pembrolizumab
42369878_Patient	patientDrug	Crizotinib
42369878_Patient	treatmentType	Intravenous_Chemotherapy
42369878_Patient	treatmentType	Molecular_Targeted_Therapy
42369878_Patient	treatmentType	Immunotherapy
42369878_Patient	patientDrug	Nivolumab
52369878_Patient	hasGender	Male
52369878_Patient	hasAgeCategory	Young
52369878_Patient	hasStage	IIIB
52369878_Patient	hasSmokingHabit	NonSmoker
52369878_Patient	hasBiomarker	ALK_Positive
52369878_Patient	hasBiomarker	EGFR_Negative
52369878_Patient	hasRelapse_Progression	Progression
52369878_Patient	patientDrug	Cisplatin
52369878_Patient	patientDrug	Vinorelbine
52369878_Patient	patientDrug	Pembrolizumab
52369878_Patient	patientDrug	Crizotinib
52369878_Patient	treatmentType	Intravenous_Chemotherapy
52369878_Patient	treatmentType	Molecular_Targeted_Therapy
52369878_Patient	treatmentType	Immunotherapy
52369878_Patient	patientDrug	Nivolumab
02670938_Patient	hasGender	Male
02670938_Patient	hasAgeCategory	Old
02670938_Patient	hasStage	IIA
02670938_Patient	hasSmokingHabit	CurrentSmoker
02670938_Patient	hasBiomarker	ALK_Negative
02670938_Patient	hasBiomarker	EGFR_Negative
02670938_Patient	hasRelapse_Progression	Progression
02670938_Patient	patientDrug	Carboplatin
02670938_Patient	patientDrug	Paclitaxel
02670938_Patient	patientDrug	Cisplatin
02670938_Patient	patientDrug	Vinorelbine
02670938_Patient	patientDrug	Pembrolizumab
02670938_Patient	patientDrug	Docetaxel
02670938_Patient	treatmentType	Intravenous_Chemotherapy
02670938_Patient	treatmentType	Immunotherapy
02670938_Patient	treatmentType	Neoadjuvant_Chemotherapy
02670938_Patient	treatmentType	Whole_Brain_Radiation_Therapy
02670938_Patient	treatmentType	Thoracoscopy
02670938_Patient	patientDrug	Nivolumab
12670938_Patient	hasGender	Male
12670938_Patient	hasAgeCategory	Old
12670938_Patient	hasStage	IIA
12670938_Patient	hasSmokingHabit	CurrentSmoker
12670938_Patient	hasBiomarker	ALK_Negative
12670938_Patient	hasBiomarker	EGFR_Negative
12670938_Patient	hasRelapse_Progression	Progression
12670938_Patient	patientDrug	Carboplatin
12670938_Patient	patientDrug	Paclitaxel
12670938_Patient	patientDrug	Cisplatin
12670938_Patient	patientDrug	Vinorelbine
12670938_Patient	patientDrug	Pembrolizumab
12670938_Patient	patientDrug	Docetaxel
12670938_Patient	treatmentType	Intravenous_Chemotherapy
12670938_Patient	treatmentType	Immunotherapy
12670938_Patient	treatmentType	Neoadjuvant_Chemotherapy
12670938_Patient	treatmentType	Whole_Brain_Radiation_Therapy
12670938_Patient	treatmentType	Thoracoscopy
12670938_Patient	patientDrug	Nivolumab
22670938_Patient	hasGender	Male
22670938_Patient	hasAgeCategory	Old
22670938_Patient	hasStage	IIA
22670938_Patient	hasSmokingHabit	CurrentSmoker
22670938_Patient	hasBiomarker	ALK_Negative
22670938_Patient	hasBiomarker	EGFR_Negative
22670938_Patient	hasRelapse_Progression	Progression
22670938_Patient	patientDrug	Carboplatin
22670938_Patient	patientDrug	Paclitaxel
22670938_Patient	patientDrug	Cisplatin
22670938_Patient	patientDrug	Vinorelbine
22670938_Patient	patientDrug	Pembrolizumab
22670938_Patient	patientDrug	Docetaxel
22670938_Patient	treatmentType	Intravenous_Chemotherapy
22670938_Patient	treatmentType	Immunotherapy
22670938_Patient	treatmentType	Neoadjuvant_Chemotherapy
22670938_Patient	treatmentType	Whole_Brain_Radiation_Therapy
22670938_Patient	treatmentType	Thoracoscopy
22670938_Patient	patientDrug	Nivolumab
32670938_Patient	hasGender	Male
32670938_Patient	hasAgeCategory	Old
32670938_Patient	hasStage	IIA
32670938_Patient	hasSmokingHabit	CurrentSmoker
32670938_Patient	hasBiomarker	ALK_Negative
32670938_Patient	hasBiomarker	EGFR_Negative
32670938_Patient	hasRelapse_Progression	Progression
32670938_Patient	patientDrug	Carboplatin
32670938_Patient	patientDrug	Paclitaxel
32670938_Patient	patientDrug	Cisplatin
32670938_Patient	patientDrug	Vinorelbine
32670938_Patient	patientDrug	Pembrolizumab
32670938_Patient	patientDrug	Docetaxel
32670938_Patient	treatmentType	Intravenous_Chemotherapy
32670938_Patient	treatmentType	Immunotherapy
32670938_Patient	treatmentType	Neoadjuvant_Chemotherapy
32670938_Patient	treatmentType	Whole_Brain_Radiation_Therapy
32670938_Patient	treatmentType	Thoracoscopy
32670938_Patient	patientDrug	Nivolumab
42670938_Patient	hasGender	Male
42670938_Patient	hasAgeCategory	Old
42670938_Patient	hasStage	IIA
42670938_Patient	hasSmokingHabit	CurrentSmoker
42670938_Patient	hasBiomarker	ALK_Negative
42670938_Patient	hasBiomarker	EGFR_Negative
42670938_Patient	hasRelapse_Progression	Progression
42670938_Patient	patientDrug	Carboplatin
42670938_Patient	patientDrug	Paclitaxel
42670938_Patient	patientDrug	Cisplatin
42670938_Patient	patientDrug	Vinorelbine
42670938_Patient	patientDrug	Pembrolizumab
42670938_Patient	patientDrug	Docetaxel
42670938_Patient	treatmentType	Intravenous_Chemotherapy
42670938_Patient	treatmentType	Immunotherapy
42670938_Patient	treatmentType	Neoadjuvant_Chemotherapy
42670938_Patient	treatmentType	Whole_Brain_Radiation_Therapy
42670938_Patient	treatmentType	Thoracoscopy
42670938_Patient	patientDrug	Nivolumab
52670938_Patient	hasGender	Male
52670938_Patient	hasAgeCategory	Old
52670938_Patient	hasStage	IIA
52670938_Patient	hasSmokingHabit	CurrentSmoker
52670938_Patient	hasBiomarker	ALK_Negative
52670938_Patient	hasBiomarker	EGFR_Negative
52670938_Patient	hasRelapse_Progression	Progression
52670938_Patient	patientDrug	Carboplatin
52670938_Patient	patientDrug	Paclitaxel
52670938_Patient	patientDrug	Cisplatin
52670938_Patient	patientDrug	Vinorelbine
52670938_Patient	patientDrug	Pembrolizumab
52670938_Patient	patientDrug	Docetaxel
52670938_Patient	treatmentType	Intravenous_Chemotherapy
52670938_Patient	treatmentType	Immunotherapy
52670938_Patient	treatmentType	Neoadjuvant_Chemotherapy
52670938_Patient	treatmentType	Whole_Brain_Radiation_Therapy
52670938_Patient	treatmentType	Thoracoscopy
52670938_Patient	patientDrug	Nivolumab
02777040_Patient	hasGender	Female
02777040_Patient	hasAgeCategory	Young
02777040_Patient	hasStage	IVB
02777040_Patient	hasSmokingHabit	CurrentSmoker
02777040_Patient	hasBiomarker	PDL1_Positive
02777040_Patient	hasBiomarker	ALK_Negative
02777040_Patient	hasBiomarker	EGFR_Negative
02777040_Patient	hasBiomarker	ROS1_Negative
02777040_Patient	hasRelapse_Progression	Progression
02777040_Patient	patientDrug	Carboplatin
02777040_Patient	patientDrug	Pemetrexed
02777040_Patient	patientDrug	Pembrolizumab
02777040_Patient	treatmentType	Intravenous_Chemotherapy
02777040_Patient	treatmentType	Immunotherapy
02777040_Patient	treatmentType	Whole_Brain_Radiation_Therapy
02777040_Patient	patientDrug	Nivolumab
12777040_Patient	hasGender	Female
12777040_Patient	hasAgeCategory	Young
12777040_Patient	hasStage	IVB
12777040_Patient	hasSmokingHabit	CurrentSmoker
12777040_Patient	hasBiomarker	PDL1_Positive
12777040_Patient	hasBiomarker	ALK_Negative
12777040_Patient	hasBiomarker	EGFR_Negative
12777040_Patient	hasBiomarker	ROS1_Negative
12777040_Patient	hasRelapse_Progression	Progression
12777040_Patient	patientDrug	Carboplatin
12777040_Patient	patientDrug	Pemetrexed
12777040_Patient	patientDrug	Pembrolizumab
12777040_Patient	treatmentType	Intravenous_Chemotherapy
12777040_Patient	treatmentType	Immunotherapy
12777040_Patient	treatmentType	Whole_Brain_Radiation_Therapy
12777040_Patient	patientDrug	Nivolumab
22777040_Patient	hasGender	Female
22777040_Patient	hasAgeCategory	Young
22777040_Patient	hasStage	IVB
22777040_Patient	hasSmokingHabit	CurrentSmoker
22777040_Patient	hasBiomarker	PDL1_Positive
22777040_Patient	hasBiomarker	ALK_Negative
22777040_Patient	hasBiomarker	EGFR_Negative
22777040_Patient	hasBiomarker	ROS1_Negative
22777040_Patient	hasRelapse_Progression	Progression
22777040_Patient	patientDrug	Carboplatin
22777040_Patient	patientDrug	Pemetrexed
22777040_Patient	patientDrug	Pembrolizumab
22777040_Patient	treatmentType	Intravenous_Chemotherapy
22777040_Patient	treatmentType	Immunotherapy
22777040_Patient	treatmentType	Whole_Brain_Radiation_Therapy
22777040_Patient	patientDrug	Nivolumab
32777040_Patient	hasGender	Female
32777040_Patient	hasAgeCategory	Young
32777040_Patient	hasStage	IVB
32777040_Patient	hasSmokingHabit	CurrentSmoker
32777040_Patient	hasBiomarker	PDL1_Positive
32777040_Patient	hasBiomarker	ALK_Negative
32777040_Patient	hasBiomarker	EGFR_Negative
32777040_Patient	hasBiomarker	ROS1_Negative
32777040_Patient	hasRelapse_Progression	Progression
32777040_Patient	patientDrug	Carboplatin
32777040_Patient	patientDrug	Pemetrexed
32777040_Patient	patientDrug	Pembrolizumab
32777040_Patient	treatmentType	Intravenous_Chemotherapy
32777040_Patient	treatmentType	Immunotherapy
32777040_Patient	treatmentType	Whole_Brain_Radiation_Therapy
32777040_Patient	patientDrug	Nivolumab
42777040_Patient	hasGender	Female
42777040_Patient	hasAgeCategory	Young
42777040_Patient	hasStage	IVB
42777040_Patient	hasSmokingHabit	CurrentSmoker
42777040_Patient	hasBiomarker	PDL1_Positive
42777040_Patient	hasBiomarker	ALK_Negative
42777040_Patient	hasBiomarker	EGFR_Negative
42777040_Patient	hasBiomarker	ROS1_Negative
42777040_Patient	hasRelapse_Progression	Progression
42777040_Patient	patientDrug	Carboplatin
42777040_Patient	patientDrug	Pemetrexed
42777040_Patient	patientDrug	Pembrolizumab
42777040_Patient	treatmentType	Intravenous_Chemotherapy
42777040_Patient	treatmentType	Immunotherapy
42777040_Patient	treatmentType	Whole_Brain_Radiation_Therapy
42777040_Patient	patientDrug	Nivolumab
52777040_Patient	hasGender	Female
52777040_Patient	hasAgeCategory	Young
52777040_Patient	hasStage	IVB
52777040_Patient	hasSmokingHabit	CurrentSmoker
52777040_Patient	hasBiomarker	PDL1_Positive
52777040_Patient	hasBiomarker	ALK_Negative
52777040_Patient	hasBiomarker	EGFR_Negative
52777040_Patient	hasBiomarker	ROS1_Negative
52777040_Patient	hasRelapse_Progression	Progression
52777040_Patient	patientDrug	Carboplatin
52777040_Patient	patientDrug	Pemetrexed
52777040_Patient	patientDrug	Pembrolizumab
52777040_Patient	treatmentType	Intravenous_Chemotherapy
52777040_Patient	treatmentType	Immunotherapy
52777040_Patient	treatmentType	Whole_Brain_Radiation_Therapy
52777040_Patient	patientDrug	Nivolumab
02803612_Patient	hasGender	Male
02803612_Patient	hasAgeCategory	Old
02803612_Patient	hasStage	IVA
02803612_Patient	hasSmokingHabit	CurrentSmoker
02803612_Patient	hasBiomarker	PDL1_Positive
02803612_Patient	hasBiomarker	ALK_Negative
02803612_Patient	hasBiomarker	EGFR_Negative
02803612_Patient	hasBiomarker	ROS1_Negative
02803612_Patient	hasRelapse_Progression	Progression
02803612_Patient	hasRelapse_Progression	Relapse
02803612_Patient	patientDrug	Paclitaxel
02803612_Patient	patientDrug	Pemetrexed
02803612_Patient	patientDrug	Cisplatin
02803612_Patient	patientDrug	Pembrolizumab
02803612_Patient	treatmentType	Intravenous_Chemotherapy
02803612_Patient	treatmentType	Concurrent_Chemoradiotherapy
02803612_Patient	treatmentType	Immunotherapy
02803612_Patient	treatmentType	Radiotherapy_To_Lung
02803612_Patient	patientDrug	Nivolumab
12803612_Patient	hasGender	Male
12803612_Patient	hasAgeCategory	Old
12803612_Patient	hasStage	IVA
12803612_Patient	hasSmokingHabit	CurrentSmoker
12803612_Patient	hasBiomarker	PDL1_Positive
12803612_Patient	hasBiomarker	ALK_Negative
12803612_Patient	hasBiomarker	EGFR_Negative
12803612_Patient	hasBiomarker	ROS1_Negative
12803612_Patient	hasRelapse_Progression	Progression
12803612_Patient	hasRelapse_Progression	Relapse
12803612_Patient	patientDrug	Paclitaxel
12803612_Patient	patientDrug	Pemetrexed
12803612_Patient	patientDrug	Cisplatin
12803612_Patient	patientDrug	Pembrolizumab
12803612_Patient	treatmentType	Intravenous_Chemotherapy
12803612_Patient	treatmentType	Concurrent_Chemoradiotherapy
12803612_Patient	treatmentType	Immunotherapy
12803612_Patient	treatmentType	Radiotherapy_To_Lung
12803612_Patient	patientDrug	Nivolumab
22803612_Patient	hasGender	Male
22803612_Patient	hasAgeCategory	Old
22803612_Patient	hasStage	IVA
22803612_Patient	hasSmokingHabit	CurrentSmoker
22803612_Patient	hasBiomarker	PDL1_Positive
22803612_Patient	hasBiomarker	ALK_Negative
22803612_Patient	hasBiomarker	EGFR_Negative
22803612_Patient	hasBiomarker	ROS1_Negative
22803612_Patient	hasRelapse_Progression	Progression
22803612_Patient	hasRelapse_Progression	Relapse
22803612_Patient	patientDrug	Paclitaxel
22803612_Patient	patientDrug	Pemetrexed
22803612_Patient	patientDrug	Cisplatin
22803612_Patient	patientDrug	Pembrolizumab
22803612_Patient	treatmentType	Intravenous_Chemotherapy
22803612_Patient	treatmentType	Concurrent_Chemoradiotherapy
22803612_Patient	treatmentType	Immunotherapy
22803612_Patient	treatmentType	Radiotherapy_To_Lung
22803612_Patient	patientDrug	Nivolumab
32803612_Patient	hasGender	Male
32803612_Patient	hasAgeCategory	Old
32803612_Patient	hasStage	IVA
32803612_Patient	hasSmokingHabit	CurrentSmoker
32803612_Patient	hasBiomarker	PDL1_Positive
32803612_Patient	hasBiomarker	ALK_Negative
32803612_Patient	hasBiomarker	EGFR_Negative
32803612_Patient	hasBiomarker	ROS1_Negative
32803612_Patient	hasRelapse_Progression	Progression
32803612_Patient	hasRelapse_Progression	Relapse
32803612_Patient	patientDrug	Paclitaxel
32803612_Patient	patientDrug	Pemetrexed
32803612_Patient	patientDrug	Cisplatin
32803612_Patient	patientDrug	Pembrolizumab
32803612_Patient	treatmentType	Intravenous_Chemotherapy
32803612_Patient	treatmentType	Concurrent_Chemoradiotherapy
32803612_Patient	treatmentType	Immunotherapy
32803612_Patient	treatmentType	Radiotherapy_To_Lung
32803612_Patient	patientDrug	Nivolumab
42803612_Patient	hasGender	Male
42803612_Patient	hasAgeCategory	Old
42803612_Patient	hasStage	IVA
42803612_Patient	hasSmokingHabit	CurrentSmoker
42803612_Patient	hasBiomarker	PDL1_Positive
42803612_Patient	hasBiomarker	ALK_Negative
42803612_Patient	hasBiomarker	EGFR_Negative
42803612_Patient	hasBiomarker	ROS1_Negative
42803612_Patient	hasRelapse_Progression	Progression
42803612_Patient	hasRelapse_Progression	Relapse
42803612_Patient	patientDrug	Paclitaxel
42803612_Patient	patientDrug	Pemetrexed
42803612_Patient	patientDrug	Cisplatin
42803612_Patient	patientDrug	Pembrolizumab
42803612_Patient	treatmentType	Intravenous_Chemotherapy
42803612_Patient	treatmentType	Concurrent_Chemoradiotherapy
42803612_Patient	treatmentType	Immunotherapy
42803612_Patient	treatmentType	Radiotherapy_To_Lung
42803612_Patient	patientDrug	Nivolumab
52803612_Patient	hasGender	Male
52803612_Patient	hasAgeCategory	Old
52803612_Patient	hasStage	IVA
52803612_Patient	hasSmokingHabit	CurrentSmoker
52803612_Patient	hasBiomarker	PDL1_Positive
52803612_Patient	hasBiomarker	ALK_Negative
52803612_Patient	hasBiomarker	EGFR_Negative
52803612_Patient	hasBiomarker	ROS1_Negative
52803612_Patient	hasRelapse_Progression	Progression
52803612_Patient	hasRelapse_Progression	Relapse
52803612_Patient	patientDrug	Paclitaxel
52803612_Patient	patientDrug	Pemetrexed
52803612_Patient	patientDrug	Cisplatin
52803612_Patient	patientDrug	Pembrolizumab
52803612_Patient	treatmentType	Intravenous_Chemotherapy
52803612_Patient	treatmentType	Concurrent_Chemoradiotherapy
52803612_Patient	treatmentType	Immunotherapy
52803612_Patient	treatmentType	Radiotherapy_To_Lung
52803612_Patient	patientDrug	Nivolumab
02825213_Patient	hasGender	Female
02825213_Patient	hasAgeCategory	Young
02825213_Patient	hasStage	IVB
02825213_Patient	hasSmokingHabit	FormerSmoker
02825213_Patient	hasBiomarker	PDL1_Positive
02825213_Patient	hasBiomarker	ALK_Negative
02825213_Patient	hasBiomarker	EGFR_Negative
02825213_Patient	hasBiomarker	ROS1_Negative
02825213_Patient	hasRelapse_Progression	Progression
02825213_Patient	patientDrug	Carboplatin
02825213_Patient	patientDrug	Paclitaxel
02825213_Patient	patientDrug	Other
02825213_Patient	patientDrug	Pembrolizumab
02825213_Patient	patientDrug	Docetaxel
02825213_Patient	treatmentType	Intravenous_Chemotherapy
02825213_Patient	treatmentType	Immunotherapy
02825213_Patient	treatmentType	Whole_Brain_Radiation_Therapy
02825213_Patient	treatmentType	Open_Surgical_Procedure
02825213_Patient	patientDrug	Nivolumab
12825213_Patient	hasGender	Female
12825213_Patient	hasAgeCategory	Young
12825213_Patient	hasStage	IVB
12825213_Patient	hasSmokingHabit	FormerSmoker
12825213_Patient	hasBiomarker	PDL1_Positive
12825213_Patient	hasBiomarker	ALK_Negative
12825213_Patient	hasBiomarker	EGFR_Negative
12825213_Patient	hasBiomarker	ROS1_Negative
12825213_Patient	hasRelapse_Progression	Progression
12825213_Patient	patientDrug	Carboplatin
12825213_Patient	patientDrug	Paclitaxel
12825213_Patient	patientDrug	Other
12825213_Patient	patientDrug	Pembrolizumab
12825213_Patient	patientDrug	Docetaxel
12825213_Patient	treatmentType	Intravenous_Chemotherapy
12825213_Patient	treatmentType	Immunotherapy
12825213_Patient	treatmentType	Whole_Brain_Radiation_Therapy
12825213_Patient	treatmentType	Open_Surgical_Procedure
12825213_Patient	patientDrug	Nivolumab
22825213_Patient	hasGender	Female
22825213_Patient	hasAgeCategory	Young
22825213_Patient	hasStage	IVB
22825213_Patient	hasSmokingHabit	FormerSmoker
22825213_Patient	hasBiomarker	PDL1_Positive
22825213_Patient	hasBiomarker	ALK_Negative
22825213_Patient	hasBiomarker	EGFR_Negative
22825213_Patient	hasBiomarker	ROS1_Negative
22825213_Patient	hasRelapse_Progression	Progression
22825213_Patient	patientDrug	Carboplatin
22825213_Patient	patientDrug	Paclitaxel
22825213_Patient	patientDrug	Other
22825213_Patient	patientDrug	Pembrolizumab
22825213_Patient	patientDrug	Docetaxel
22825213_Patient	treatmentType	Intravenous_Chemotherapy
22825213_Patient	treatmentType	Immunotherapy
22825213_Patient	treatmentType	Whole_Brain_Radiation_Therapy
22825213_Patient	treatmentType	Open_Surgical_Procedure
22825213_Patient	patientDrug	Nivolumab
32825213_Patient	hasGender	Female
32825213_Patient	hasAgeCategory	Young
32825213_Patient	hasStage	IVB
32825213_Patient	hasSmokingHabit	FormerSmoker
32825213_Patient	hasBiomarker	PDL1_Positive
32825213_Patient	hasBiomarker	ALK_Negative
32825213_Patient	hasBiomarker	EGFR_Negative
32825213_Patient	hasBiomarker	ROS1_Negative
32825213_Patient	hasRelapse_Progression	Progression
32825213_Patient	patientDrug	Carboplatin
32825213_Patient	patientDrug	Paclitaxel
32825213_Patient	patientDrug	Other
32825213_Patient	patientDrug	Pembrolizumab
32825213_Patient	patientDrug	Docetaxel
32825213_Patient	treatmentType	Intravenous_Chemotherapy
32825213_Patient	treatmentType	Immunotherapy
32825213_Patient	treatmentType	Whole_Brain_Radiation_Therapy
32825213_Patient	treatmentType	Open_Surgical_Procedure
32825213_Patient	patientDrug	Nivolumab
42825213_Patient	hasGender	Female
42825213_Patient	hasAgeCategory	Young
42825213_Patient	hasStage	IVB
42825213_Patient	hasSmokingHabit	FormerSmoker
42825213_Patient	hasBiomarker	PDL1_Positive
42825213_Patient	hasBiomarker	ALK_Negative
42825213_Patient	hasBiomarker	EGFR_Negative
42825213_Patient	hasBiomarker	ROS1_Negative
42825213_Patient	hasRelapse_Progression	Progression
42825213_Patient	patientDrug	Carboplatin
42825213_Patient	patientDrug	Paclitaxel
42825213_Patient	patientDrug	Other
42825213_Patient	patientDrug	Pembrolizumab
42825213_Patient	patientDrug	Docetaxel
42825213_Patient	treatmentType	Intravenous_Chemotherapy
42825213_Patient	treatmentType	Immunotherapy
42825213_Patient	treatmentType	Whole_Brain_Radiation_Therapy
42825213_Patient	treatmentType	Open_Surgical_Procedure
42825213_Patient	patientDrug	Nivolumab
52825213_Patient	hasGender	Female
52825213_Patient	hasAgeCategory	Young
52825213_Patient	hasStage	IVB
52825213_Patient	hasSmokingHabit	FormerSmoker
52825213_Patient	hasBiomarker	PDL1_Positive
52825213_Patient	hasBiomarker	ALK_Negative
52825213_Patient	hasBiomarker	EGFR_Negative
52825213_Patient	hasBiomarker	ROS1_Negative
52825213_Patient	hasRelapse_Progression	Progression
52825213_Patient	patientDrug	Carboplatin
52825213_Patient	patientDrug	Paclitaxel
52825213_Patient	patientDrug	Other
52825213_Patient	patientDrug	Pembrolizumab
52825213_Patient	patientDrug	Docetaxel
52825213_Patient	treatmentType	Intravenous_Chemotherapy
52825213_Patient	treatmentType	Immunotherapy
52825213_Patient	treatmentType	Whole_Brain_Radiation_Therapy
52825213_Patient	treatmentType	Open_Surgical_Procedure
52825213_Patient	patientDrug	Nivolumab
02834441_Patient	hasGender	Male
02834441_Patient	hasAgeCategory	Young
02834441_Patient	hasStage	IVB
02834441_Patient	hasSmokingHabit	CurrentSmoker
02834441_Patient	hasBiomarker	PDL1_Positive
02834441_Patient	hasBiomarker	ALK_Negative
02834441_Patient	hasBiomarker	EGFR_Negative
02834441_Patient	hasBiomarker	KRAS_Negative
02834441_Patient	hasBiomarker	MET_Negative
02834441_Patient	hasBiomarker	RET_Negative
02834441_Patient	hasBiomarker	ROS1_Negative
02834441_Patient	hasRelapse_Progression	Progression
02834441_Patient	patientDrug	Atezolizumab
02834441_Patient	patientDrug	Pemetrexed
02834441_Patient	patientDrug	Cisplatin
02834441_Patient	patientDrug	Gemcitabine
02834441_Patient	patientDrug	Other
02834441_Patient	patientDrug	Docetaxel
02834441_Patient	patientDrug	Nintedanib
02834441_Patient	treatmentType	Intravenous_Chemotherapy
02834441_Patient	treatmentType	Immunotherapy
02834441_Patient	treatmentType	Whole_Brain_Radiation_Therapy
02834441_Patient	patientDrug	Nivolumab
12834441_Patient	hasGender	Male
12834441_Patient	hasAgeCategory	Young
12834441_Patient	hasStage	IVB
12834441_Patient	hasSmokingHabit	CurrentSmoker
12834441_Patient	hasBiomarker	PDL1_Positive
12834441_Patient	hasBiomarker	ALK_Negative
12834441_Patient	hasBiomarker	EGFR_Negative
12834441_Patient	hasBiomarker	KRAS_Negative
12834441_Patient	hasBiomarker	MET_Negative
12834441_Patient	hasBiomarker	RET_Negative
12834441_Patient	hasBiomarker	ROS1_Negative
12834441_Patient	hasRelapse_Progression	Progression
12834441_Patient	patientDrug	Atezolizumab
12834441_Patient	patientDrug	Pemetrexed
12834441_Patient	patientDrug	Cisplatin
12834441_Patient	patientDrug	Gemcitabine
12834441_Patient	patientDrug	Other
12834441_Patient	patientDrug	Docetaxel
12834441_Patient	patientDrug	Nintedanib
12834441_Patient	treatmentType	Intravenous_Chemotherapy
12834441_Patient	treatmentType	Immunotherapy
12834441_Patient	treatmentType	Whole_Brain_Radiation_Therapy
12834441_Patient	patientDrug	Nivolumab
22834441_Patient	hasGender	Male
22834441_Patient	hasAgeCategory	Young
22834441_Patient	hasStage	IVB
22834441_Patient	hasSmokingHabit	CurrentSmoker
22834441_Patient	hasBiomarker	PDL1_Positive
22834441_Patient	hasBiomarker	ALK_Negative
22834441_Patient	hasBiomarker	EGFR_Negative
22834441_Patient	hasBiomarker	KRAS_Negative
22834441_Patient	hasBiomarker	MET_Negative
22834441_Patient	hasBiomarker	RET_Negative
22834441_Patient	hasBiomarker	ROS1_Negative
22834441_Patient	hasRelapse_Progression	Progression
22834441_Patient	patientDrug	Atezolizumab
22834441_Patient	patientDrug	Pemetrexed
22834441_Patient	patientDrug	Cisplatin
22834441_Patient	patientDrug	Gemcitabine
22834441_Patient	patientDrug	Other
22834441_Patient	patientDrug	Docetaxel
22834441_Patient	patientDrug	Nintedanib
22834441_Patient	treatmentType	Intravenous_Chemotherapy
22834441_Patient	treatmentType	Immunotherapy
22834441_Patient	treatmentType	Whole_Brain_Radiation_Therapy
22834441_Patient	patientDrug	Nivolumab
32834441_Patient	hasGender	Male
32834441_Patient	hasAgeCategory	Young
32834441_Patient	hasStage	IVB
32834441_Patient	hasSmokingHabit	CurrentSmoker
32834441_Patient	hasBiomarker	PDL1_Positive
32834441_Patient	hasBiomarker	ALK_Negative
32834441_Patient	hasBiomarker	EGFR_Negative
32834441_Patient	hasBiomarker	KRAS_Negative
32834441_Patient	hasBiomarker	MET_Negative
32834441_Patient	hasBiomarker	RET_Negative
32834441_Patient	hasBiomarker	ROS1_Negative
32834441_Patient	hasRelapse_Progression	Progression
32834441_Patient	patientDrug	Atezolizumab
32834441_Patient	patientDrug	Pemetrexed
32834441_Patient	patientDrug	Cisplatin
32834441_Patient	patientDrug	Gemcitabine
32834441_Patient	patientDrug	Other
32834441_Patient	patientDrug	Docetaxel
32834441_Patient	patientDrug	Nintedanib
32834441_Patient	treatmentType	Intravenous_Chemotherapy
32834441_Patient	treatmentType	Immunotherapy
32834441_Patient	treatmentType	Whole_Brain_Radiation_Therapy
32834441_Patient	patientDrug	Nivolumab
42834441_Patient	hasGender	Male
42834441_Patient	hasAgeCategory	Young
42834441_Patient	hasStage	IVB
42834441_Patient	hasSmokingHabit	CurrentSmoker
42834441_Patient	hasBiomarker	PDL1_Positive
42834441_Patient	hasBiomarker	ALK_Negative
42834441_Patient	hasBiomarker	EGFR_Negative
42834441_Patient	hasBiomarker	KRAS_Negative
42834441_Patient	hasBiomarker	MET_Negative
42834441_Patient	hasBiomarker	RET_Negative
42834441_Patient	hasBiomarker	ROS1_Negative
42834441_Patient	hasRelapse_Progression	Progression
42834441_Patient	patientDrug	Atezolizumab
42834441_Patient	patientDrug	Pemetrexed
42834441_Patient	patientDrug	Cisplatin
42834441_Patient	patientDrug	Gemcitabine
42834441_Patient	patientDrug	Other
42834441_Patient	patientDrug	Docetaxel
42834441_Patient	patientDrug	Nintedanib
42834441_Patient	treatmentType	Intravenous_Chemotherapy
42834441_Patient	treatmentType	Immunotherapy
42834441_Patient	treatmentType	Whole_Brain_Radiation_Therapy
42834441_Patient	patientDrug	Nivolumab
52834441_Patient	hasGender	Male
52834441_Patient	hasAgeCategory	Young
52834441_Patient	hasStage	IVB
52834441_Patient	hasSmokingHabit	CurrentSmoker
52834441_Patient	hasBiomarker	PDL1_Positive
52834441_Patient	hasBiomarker	ALK_Negative
52834441_Patient	hasBiomarker	EGFR_Negative
52834441_Patient	hasBiomarker	KRAS_Negative
52834441_Patient	hasBiomarker	MET_Negative
52834441_Patient	hasBiomarker	RET_Negative
52834441_Patient	hasBiomarker	ROS1_Negative
52834441_Patient	hasRelapse_Progression	Progression
52834441_Patient	patientDrug	Atezolizumab
52834441_Patient	patientDrug	Pemetrexed
52834441_Patient	patientDrug	Cisplatin
52834441_Patient	patientDrug	Gemcitabine
52834441_Patient	patientDrug	Other
52834441_Patient	patientDrug	Docetaxel
52834441_Patient	patientDrug	Nintedanib
52834441_Patient	treatmentType	Intravenous_Chemotherapy
52834441_Patient	treatmentType	Immunotherapy
52834441_Patient	treatmentType	Whole_Brain_Radiation_Therapy
52834441_Patient	patientDrug	Nivolumab
0438540_Patient	hasGender	Male
0438540_Patient	hasAgeCategory	Old
0438540_Patient	hasStage	IVA
0438540_Patient	hasSmokingHabit	FormerSmoker
0438540_Patient	hasBiomarker	EGFR_Positive
0438540_Patient	hasBiomarker	ALK_Negative
0438540_Patient	hasBiomarker	PDL1_Negative
0438540_Patient	hasBiomarker	ROS1_Negative
0438540_Patient	hasRelapse_Progression	Progression
0438540_Patient	patientDrug	Carboplatin
0438540_Patient	patientDrug	Atezolizumab
0438540_Patient	patientDrug	Pemetrexed
0438540_Patient	treatmentType	Intravenous_Chemotherapy
0438540_Patient	treatmentType	Immunotherapy
0438540_Patient	treatmentType	Thoracoscopy
1438540_Patient	hasGender	Male
1438540_Patient	hasAgeCategory	Old
1438540_Patient	hasStage	IVA
1438540_Patient	hasSmokingHabit	FormerSmoker
1438540_Patient	hasBiomarker	EGFR_Positive
1438540_Patient	hasBiomarker	ALK_Negative
1438540_Patient	hasBiomarker	PDL1_Negative
1438540_Patient	hasBiomarker	ROS1_Negative
1438540_Patient	hasRelapse_Progression	Progression
1438540_Patient	patientDrug	Carboplatin
1438540_Patient	patientDrug	Atezolizumab
1438540_Patient	patientDrug	Pemetrexed
1438540_Patient	treatmentType	Intravenous_Chemotherapy
1438540_Patient	treatmentType	Immunotherapy
1438540_Patient	treatmentType	Thoracoscopy
2438540_Patient	hasGender	Male
2438540_Patient	hasAgeCategory	Old
2438540_Patient	hasStage	IVA
2438540_Patient	hasSmokingHabit	FormerSmoker
2438540_Patient	hasBiomarker	EGFR_Positive
2438540_Patient	hasBiomarker	ALK_Negative
2438540_Patient	hasBiomarker	PDL1_Negative
2438540_Patient	hasBiomarker	ROS1_Negative
2438540_Patient	hasRelapse_Progression	Progression
2438540_Patient	patientDrug	Carboplatin
2438540_Patient	patientDrug	Atezolizumab
2438540_Patient	patientDrug	Pemetrexed
2438540_Patient	treatmentType	Intravenous_Chemotherapy
2438540_Patient	treatmentType	Immunotherapy
2438540_Patient	treatmentType	Thoracoscopy
3438540_Patient	hasGender	Male
3438540_Patient	hasAgeCategory	Old
3438540_Patient	hasStage	IVA
3438540_Patient	hasSmokingHabit	FormerSmoker
3438540_Patient	hasBiomarker	EGFR_Positive
3438540_Patient	hasBiomarker	ALK_Negative
3438540_Patient	hasBiomarker	PDL1_Negative
3438540_Patient	hasBiomarker	ROS1_Negative
3438540_Patient	hasRelapse_Progression	Progression
3438540_Patient	patientDrug	Carboplatin
3438540_Patient	patientDrug	Atezolizumab
3438540_Patient	patientDrug	Pemetrexed
3438540_Patient	treatmentType	Intravenous_Chemotherapy
3438540_Patient	treatmentType	Immunotherapy
3438540_Patient	treatmentType	Thoracoscopy
4438540_Patient	hasGender	Male
4438540_Patient	hasAgeCategory	Old
4438540_Patient	hasStage	IVA
4438540_Patient	hasSmokingHabit	FormerSmoker
4438540_Patient	hasBiomarker	EGFR_Positive
4438540_Patient	hasBiomarker	ALK_Negative
4438540_Patient	hasBiomarker	PDL1_Negative
4438540_Patient	hasBiomarker	ROS1_Negative
4438540_Patient	hasRelapse_Progression	Progression
4438540_Patient	patientDrug	Carboplatin
4438540_Patient	patientDrug	Atezolizumab
4438540_Patient	patientDrug	Pemetrexed
4438540_Patient	treatmentType	Intravenous_Chemotherapy
4438540_Patient	treatmentType	Immunotherapy
4438540_Patient	treatmentType	Thoracoscopy
5438540_Patient	hasGender	Male
5438540_Patient	hasAgeCategory	Old
5438540_Patient	hasStage	IVA
5438540_Patient	hasSmokingHabit	FormerSmoker
5438540_Patient	hasBiomarker	EGFR_Positive
5438540_Patient	hasBiomarker	ALK_Negative
5438540_Patient	hasBiomarker	PDL1_Negative
5438540_Patient	hasBiomarker	ROS1_Negative
5438540_Patient	hasRelapse_Progression	Progression
5438540_Patient	patientDrug	Carboplatin
5438540_Patient	patientDrug	Atezolizumab
5438540_Patient	patientDrug	Pemetrexed
5438540_Patient	treatmentType	Intravenous_Chemotherapy
5438540_Patient	treatmentType	Immunotherapy
5438540_Patient	treatmentType	Thoracoscopy
0576411_Patient	hasGender	Female
0576411_Patient	hasAgeCategory	Young
0576411_Patient	hasStage	IIIB
0576411_Patient	hasSmokingHabit	FormerSmoker
0576411_Patient	hasBiomarker	EGFR_Positive
0576411_Patient	hasRelapse_Progression	Progression
0576411_Patient	patientDrug	Paclitaxel
0576411_Patient	patientDrug	Pemetrexed
0576411_Patient	patientDrug	Cisplatin
0576411_Patient	patientDrug	Pembrolizumab
0576411_Patient	treatmentType	Intravenous_Chemotherapy
0576411_Patient	treatmentType	Concurrent_Chemoradiotherapy
0576411_Patient	treatmentType	Immunotherapy
0576411_Patient	treatmentType	Radiotherapy_To_Lung
1576411_Patient	hasGender	Female
1576411_Patient	hasAgeCategory	Young
1576411_Patient	hasStage	IIIB
1576411_Patient	hasSmokingHabit	FormerSmoker
1576411_Patient	hasBiomarker	EGFR_Positive
1576411_Patient	hasRelapse_Progression	Progression
1576411_Patient	patientDrug	Paclitaxel
1576411_Patient	patientDrug	Pemetrexed
1576411_Patient	patientDrug	Cisplatin
1576411_Patient	patientDrug	Pembrolizumab
1576411_Patient	treatmentType	Intravenous_Chemotherapy
1576411_Patient	treatmentType	Concurrent_Chemoradiotherapy
1576411_Patient	treatmentType	Immunotherapy
1576411_Patient	treatmentType	Radiotherapy_To_Lung
2576411_Patient	hasGender	Female
2576411_Patient	hasAgeCategory	Young
2576411_Patient	hasStage	IIIB
2576411_Patient	hasSmokingHabit	FormerSmoker
2576411_Patient	hasBiomarker	EGFR_Positive
2576411_Patient	hasRelapse_Progression	Progression
2576411_Patient	patientDrug	Paclitaxel
2576411_Patient	patientDrug	Pemetrexed
2576411_Patient	patientDrug	Cisplatin
2576411_Patient	patientDrug	Pembrolizumab
2576411_Patient	treatmentType	Intravenous_Chemotherapy
2576411_Patient	treatmentType	Concurrent_Chemoradiotherapy
2576411_Patient	treatmentType	Immunotherapy
2576411_Patient	treatmentType	Radiotherapy_To_Lung
3576411_Patient	hasGender	Female
3576411_Patient	hasAgeCategory	Young
3576411_Patient	hasStage	IIIB
3576411_Patient	hasSmokingHabit	FormerSmoker
3576411_Patient	hasBiomarker	EGFR_Positive
3576411_Patient	hasRelapse_Progression	Progression
3576411_Patient	patientDrug	Paclitaxel
3576411_Patient	patientDrug	Pemetrexed
3576411_Patient	patientDrug	Cisplatin
3576411_Patient	patientDrug	Pembrolizumab
3576411_Patient	treatmentType	Intravenous_Chemotherapy
3576411_Patient	treatmentType	Concurrent_Chemoradiotherapy
3576411_Patient	treatmentType	Immunotherapy
3576411_Patient	treatmentType	Radiotherapy_To_Lung
4576411_Patient	hasGender	Female
4576411_Patient	hasAgeCategory	Young
4576411_Patient	hasStage	IIIB
4576411_Patient	hasSmokingHabit	FormerSmoker
4576411_Patient	hasBiomarker	EGFR_Positive
4576411_Patient	hasRelapse_Progression	Progression
4576411_Patient	patientDrug	Paclitaxel
4576411_Patient	patientDrug	Pemetrexed
4576411_Patient	patientDrug	Cisplatin
4576411_Patient	patientDrug	Pembrolizumab
4576411_Patient	treatmentType	Intravenous_Chemotherapy
4576411_Patient	treatmentType	Concurrent_Chemoradiotherapy
4576411_Patient	treatmentType	Immunotherapy
4576411_Patient	treatmentType	Radiotherapy_To_Lung
5576411_Patient	hasGender	Female
5576411_Patient	hasAgeCategory	Young
5576411_Patient	hasStage	IIIB
5576411_Patient	hasSmokingHabit	FormerSmoker
5576411_Patient	hasBiomarker	EGFR_Positive
5576411_Patient	hasRelapse_Progression	Progression
5576411_Patient	patientDrug	Paclitaxel
5576411_Patient	patientDrug	Pemetrexed
5576411_Patient	patientDrug	Cisplatin
5576411_Patient	patientDrug	Pembrolizumab
5576411_Patient	treatmentType	Intravenous_Chemotherapy
5576411_Patient	treatmentType	Concurrent_Chemoradiotherapy
5576411_Patient	treatmentType	Immunotherapy
5576411_Patient	treatmentType	Radiotherapy_To_Lung
0583611_Patient	hasGender	Female
0583611_Patient	hasAgeCategory	Old
0583611_Patient	hasStage	IIIC
0583611_Patient	hasSmokingHabit	CurrentSmoker
0583611_Patient	hasBiomarker	EGFR_Positive
0583611_Patient	hasBiomarker	PDL1_Positive
0583611_Patient	hasBiomarker	ALK_Negative
0583611_Patient	hasBiomarker	ROS1_Negative
0583611_Patient	hasRelapse_Progression	No_Progression
0583611_Patient	patientDrug	Carboplatin
0583611_Patient	patientDrug	Vinorelbine
0583611_Patient	patientDrug	Durvalumab
0583611_Patient	treatmentType	Intravenous_Chemotherapy
0583611_Patient	treatmentType	Concurrent_Chemoradiotherapy
0583611_Patient	treatmentType	Immunotherapy
0583611_Patient	treatmentType	Radiotherapy_To_Lung
1583611_Patient	hasGender	Female
1583611_Patient	hasAgeCategory	Old
1583611_Patient	hasStage	IIIC
1583611_Patient	hasSmokingHabit	CurrentSmoker
1583611_Patient	hasBiomarker	EGFR_Positive
1583611_Patient	hasBiomarker	PDL1_Positive
1583611_Patient	hasBiomarker	ALK_Negative
1583611_Patient	hasBiomarker	ROS1_Negative
1583611_Patient	hasRelapse_Progression	No_Progression
1583611_Patient	patientDrug	Carboplatin
1583611_Patient	patientDrug	Vinorelbine
1583611_Patient	patientDrug	Durvalumab
1583611_Patient	treatmentType	Intravenous_Chemotherapy
1583611_Patient	treatmentType	Concurrent_Chemoradiotherapy
1583611_Patient	treatmentType	Immunotherapy
1583611_Patient	treatmentType	Radiotherapy_To_Lung
2583611_Patient	hasGender	Female
2583611_Patient	hasAgeCategory	Old
2583611_Patient	hasStage	IIIC
2583611_Patient	hasSmokingHabit	CurrentSmoker
2583611_Patient	hasBiomarker	EGFR_Positive
2583611_Patient	hasBiomarker	PDL1_Positive
2583611_Patient	hasBiomarker	ALK_Negative
2583611_Patient	hasBiomarker	ROS1_Negative
2583611_Patient	hasRelapse_Progression	No_Progression
2583611_Patient	patientDrug	Carboplatin
2583611_Patient	patientDrug	Vinorelbine
2583611_Patient	patientDrug	Durvalumab
2583611_Patient	treatmentType	Intravenous_Chemotherapy
2583611_Patient	treatmentType	Concurrent_Chemoradiotherapy
2583611_Patient	treatmentType	Immunotherapy
2583611_Patient	treatmentType	Radiotherapy_To_Lung
3583611_Patient	hasGender	Female
3583611_Patient	hasAgeCategory	Old
3583611_Patient	hasStage	IIIC
3583611_Patient	hasSmokingHabit	CurrentSmoker
3583611_Patient	hasBiomarker	EGFR_Positive
3583611_Patient	hasBiomarker	PDL1_Positive
3583611_Patient	hasBiomarker	ALK_Negative
3583611_Patient	hasBiomarker	ROS1_Negative
3583611_Patient	hasRelapse_Progression	No_Progression
3583611_Patient	patientDrug	Carboplatin
3583611_Patient	patientDrug	Vinorelbine
3583611_Patient	patientDrug	Durvalumab
3583611_Patient	treatmentType	Intravenous_Chemotherapy
3583611_Patient	treatmentType	Concurrent_Chemoradiotherapy
3583611_Patient	treatmentType	Immunotherapy
3583611_Patient	treatmentType	Radiotherapy_To_Lung
4583611_Patient	hasGender	Female
4583611_Patient	hasAgeCategory	Old
4583611_Patient	hasStage	IIIC
4583611_Patient	hasSmokingHabit	CurrentSmoker
4583611_Patient	hasBiomarker	EGFR_Positive
4583611_Patient	hasBiomarker	PDL1_Positive
4583611_Patient	hasBiomarker	ALK_Negative
4583611_Patient	hasBiomarker	ROS1_Negative
4583611_Patient	hasRelapse_Progression	No_Progression
4583611_Patient	patientDrug	Carboplatin
4583611_Patient	patientDrug	Vinorelbine
4583611_Patient	patientDrug	Durvalumab
4583611_Patient	treatmentType	Intravenous_Chemotherapy
4583611_Patient	treatmentType	Concurrent_Chemoradiotherapy
4583611_Patient	treatmentType	Immunotherapy
4583611_Patient	treatmentType	Radiotherapy_To_Lung
5583611_Patient	hasGender	Female
5583611_Patient	hasAgeCategory	Old
5583611_Patient	hasStage	IIIC
5583611_Patient	hasSmokingHabit	CurrentSmoker
5583611_Patient	hasBiomarker	EGFR_Positive
5583611_Patient	hasBiomarker	PDL1_Positive
5583611_Patient	hasBiomarker	ALK_Negative
5583611_Patient	hasBiomarker	ROS1_Negative
5583611_Patient	hasRelapse_Progression	No_Progression
5583611_Patient	patientDrug	Carboplatin
5583611_Patient	patientDrug	Vinorelbine
5583611_Patient	patientDrug	Durvalumab
5583611_Patient	treatmentType	Intravenous_Chemotherapy
5583611_Patient	treatmentType	Concurrent_Chemoradiotherapy
5583611_Patient	treatmentType	Immunotherapy
5583611_Patient	treatmentType	Radiotherapy_To_Lung
0619371_Patient	hasGender	Female
0619371_Patient	hasAgeCategory	Young
0619371_Patient	hasStage	IVB
0619371_Patient	hasSmokingHabit	CurrentSmoker
0619371_Patient	hasBiomarker	EGFR_Positive
0619371_Patient	hasBiomarker	PDL1_Positive
0619371_Patient	hasBiomarker	ALK_Negative
0619371_Patient	hasBiomarker	ROS1_Negative
0619371_Patient	hasRelapse_Progression	Progression
0619371_Patient	patientDrug	Carboplatin
0619371_Patient	patientDrug	Pemetrexed
0619371_Patient	patientDrug	Pembrolizumab
0619371_Patient	patientDrug	Docetaxel
0619371_Patient	treatmentType	Intravenous_Chemotherapy
0619371_Patient	treatmentType	Immunotherapy
0619371_Patient	treatmentType	Radiotherapy_To_Lung
0619371_Patient	treatmentType	Radiotherapy_To_Bone
1619371_Patient	hasGender	Female
1619371_Patient	hasAgeCategory	Young
1619371_Patient	hasStage	IVB
1619371_Patient	hasSmokingHabit	CurrentSmoker
1619371_Patient	hasBiomarker	EGFR_Positive
1619371_Patient	hasBiomarker	PDL1_Positive
1619371_Patient	hasBiomarker	ALK_Negative
1619371_Patient	hasBiomarker	ROS1_Negative
1619371_Patient	hasRelapse_Progression	Progression
1619371_Patient	patientDrug	Carboplatin
1619371_Patient	patientDrug	Pemetrexed
1619371_Patient	patientDrug	Pembrolizumab
1619371_Patient	patientDrug	Docetaxel
1619371_Patient	treatmentType	Intravenous_Chemotherapy
1619371_Patient	treatmentType	Immunotherapy
1619371_Patient	treatmentType	Radiotherapy_To_Lung
1619371_Patient	treatmentType	Radiotherapy_To_Bone
2619371_Patient	hasGender	Female
2619371_Patient	hasAgeCategory	Young
2619371_Patient	hasStage	IVB
2619371_Patient	hasSmokingHabit	CurrentSmoker
2619371_Patient	hasBiomarker	EGFR_Positive
2619371_Patient	hasBiomarker	PDL1_Positive
2619371_Patient	hasBiomarker	ALK_Negative
2619371_Patient	hasBiomarker	ROS1_Negative
2619371_Patient	hasRelapse_Progression	Progression
2619371_Patient	patientDrug	Carboplatin
2619371_Patient	patientDrug	Pemetrexed
2619371_Patient	patientDrug	Pembrolizumab
2619371_Patient	patientDrug	Docetaxel
2619371_Patient	treatmentType	Intravenous_Chemotherapy
2619371_Patient	treatmentType	Immunotherapy
2619371_Patient	treatmentType	Radiotherapy_To_Lung
2619371_Patient	treatmentType	Radiotherapy_To_Bone
3619371_Patient	hasGender	Female
3619371_Patient	hasAgeCategory	Young
3619371_Patient	hasStage	IVB
3619371_Patient	hasSmokingHabit	CurrentSmoker
3619371_Patient	hasBiomarker	EGFR_Positive
3619371_Patient	hasBiomarker	PDL1_Positive
3619371_Patient	hasBiomarker	ALK_Negative
3619371_Patient	hasBiomarker	ROS1_Negative
3619371_Patient	hasRelapse_Progression	Progression
3619371_Patient	patientDrug	Carboplatin
3619371_Patient	patientDrug	Pemetrexed
3619371_Patient	patientDrug	Pembrolizumab
3619371_Patient	patientDrug	Docetaxel
3619371_Patient	treatmentType	Intravenous_Chemotherapy
3619371_Patient	treatmentType	Immunotherapy
3619371_Patient	treatmentType	Radiotherapy_To_Lung
3619371_Patient	treatmentType	Radiotherapy_To_Bone
4619371_Patient	hasGender	Female
4619371_Patient	hasAgeCategory	Young
4619371_Patient	hasStage	IVB
4619371_Patient	hasSmokingHabit	CurrentSmoker
4619371_Patient	hasBiomarker	EGFR_Positive
4619371_Patient	hasBiomarker	PDL1_Positive
4619371_Patient	hasBiomarker	ALK_Negative
4619371_Patient	hasBiomarker	ROS1_Negative
4619371_Patient	hasRelapse_Progression	Progression
4619371_Patient	patientDrug	Carboplatin
4619371_Patient	patientDrug	Pemetrexed
4619371_Patient	patientDrug	Pembrolizumab
4619371_Patient	patientDrug	Docetaxel
4619371_Patient	treatmentType	Intravenous_Chemotherapy
4619371_Patient	treatmentType	Immunotherapy
4619371_Patient	treatmentType	Radiotherapy_To_Lung
4619371_Patient	treatmentType	Radiotherapy_To_Bone
5619371_Patient	hasGender	Female
5619371_Patient	hasAgeCategory	Young
5619371_Patient	hasStage	IVB
5619371_Patient	hasSmokingHabit	CurrentSmoker
5619371_Patient	hasBiomarker	EGFR_Positive
5619371_Patient	hasBiomarker	PDL1_Positive
5619371_Patient	hasBiomarker	ALK_Negative
5619371_Patient	hasBiomarker	ROS1_Negative
5619371_Patient	hasRelapse_Progression	Progression
5619371_Patient	patientDrug	Carboplatin
5619371_Patient	patientDrug	Pemetrexed
5619371_Patient	patientDrug	Pembrolizumab
5619371_Patient	patientDrug	Docetaxel
5619371_Patient	treatmentType	Intravenous_Chemotherapy
5619371_Patient	treatmentType	Immunotherapy
5619371_Patient	treatmentType	Radiotherapy_To_Lung
5619371_Patient	treatmentType	Radiotherapy_To_Bone
0623804_Patient	hasGender	Female
0623804_Patient	hasAgeCategory	Young
0623804_Patient	hasStage	IVB
0623804_Patient	hasSmokingHabit	CurrentSmoker
0623804_Patient	hasBiomarker	PDL1_Positive
0623804_Patient	hasBiomarker	ALK_Negative
0623804_Patient	hasBiomarker	EGFR_Negative
0623804_Patient	hasBiomarker	ROS1_Negative
0623804_Patient	hasRelapse_Progression	Progression
0623804_Patient	patientDrug	Atezolizumab
0623804_Patient	patientDrug	Pemetrexed
0623804_Patient	patientDrug	Cisplatin
0623804_Patient	patientDrug	Vinorelbine
0623804_Patient	patientDrug	Docetaxel
0623804_Patient	treatmentType	Intravenous_Chemotherapy
0623804_Patient	treatmentType	Immunotherapy
0623804_Patient	treatmentType	Whole_Brain_Radiation_Therapy
0623804_Patient	treatmentType	Radiotherapy_To_Bone
1623804_Patient	hasGender	Female
1623804_Patient	hasAgeCategory	Young
1623804_Patient	hasStage	IVB
1623804_Patient	hasSmokingHabit	CurrentSmoker
1623804_Patient	hasBiomarker	PDL1_Positive
1623804_Patient	hasBiomarker	ALK_Negative
1623804_Patient	hasBiomarker	EGFR_Negative
1623804_Patient	hasBiomarker	ROS1_Negative
1623804_Patient	hasRelapse_Progression	Progression
1623804_Patient	patientDrug	Atezolizumab
1623804_Patient	patientDrug	Pemetrexed
1623804_Patient	patientDrug	Cisplatin
1623804_Patient	patientDrug	Vinorelbine
1623804_Patient	patientDrug	Docetaxel
1623804_Patient	treatmentType	Intravenous_Chemotherapy
1623804_Patient	treatmentType	Immunotherapy
1623804_Patient	treatmentType	Whole_Brain_Radiation_Therapy
1623804_Patient	treatmentType	Radiotherapy_To_Bone
2623804_Patient	hasGender	Female
2623804_Patient	hasAgeCategory	Young
2623804_Patient	hasStage	IVB
2623804_Patient	hasSmokingHabit	CurrentSmoker
2623804_Patient	hasBiomarker	PDL1_Positive
2623804_Patient	hasBiomarker	ALK_Negative
2623804_Patient	hasBiomarker	EGFR_Negative
2623804_Patient	hasBiomarker	ROS1_Negative
2623804_Patient	hasRelapse_Progression	Progression
2623804_Patient	patientDrug	Atezolizumab
2623804_Patient	patientDrug	Pemetrexed
2623804_Patient	patientDrug	Cisplatin
2623804_Patient	patientDrug	Vinorelbine
2623804_Patient	patientDrug	Docetaxel
2623804_Patient	treatmentType	Intravenous_Chemotherapy
2623804_Patient	treatmentType	Immunotherapy
2623804_Patient	treatmentType	Whole_Brain_Radiation_Therapy
2623804_Patient	treatmentType	Radiotherapy_To_Bone
3623804_Patient	hasGender	Female
3623804_Patient	hasAgeCategory	Young
3623804_Patient	hasStage	IVB
3623804_Patient	hasSmokingHabit	CurrentSmoker
3623804_Patient	hasBiomarker	PDL1_Positive
3623804_Patient	hasBiomarker	ALK_Negative
3623804_Patient	hasBiomarker	EGFR_Negative
3623804_Patient	hasBiomarker	ROS1_Negative
3623804_Patient	hasRelapse_Progression	Progression
3623804_Patient	patientDrug	Atezolizumab
3623804_Patient	patientDrug	Pemetrexed
3623804_Patient	patientDrug	Cisplatin
3623804_Patient	patientDrug	Vinorelbine
3623804_Patient	patientDrug	Docetaxel
3623804_Patient	treatmentType	Intravenous_Chemotherapy
3623804_Patient	treatmentType	Immunotherapy
3623804_Patient	treatmentType	Whole_Brain_Radiation_Therapy
3623804_Patient	treatmentType	Radiotherapy_To_Bone
4623804_Patient	hasGender	Female
4623804_Patient	hasAgeCategory	Young
4623804_Patient	hasStage	IVB
4623804_Patient	hasSmokingHabit	CurrentSmoker
4623804_Patient	hasBiomarker	PDL1_Positive
4623804_Patient	hasBiomarker	ALK_Negative
4623804_Patient	hasBiomarker	EGFR_Negative
4623804_Patient	hasBiomarker	ROS1_Negative
4623804_Patient	hasRelapse_Progression	Progression
4623804_Patient	patientDrug	Atezolizumab
4623804_Patient	patientDrug	Pemetrexed
4623804_Patient	patientDrug	Cisplatin
4623804_Patient	patientDrug	Vinorelbine
4623804_Patient	patientDrug	Docetaxel
4623804_Patient	treatmentType	Intravenous_Chemotherapy
4623804_Patient	treatmentType	Immunotherapy
4623804_Patient	treatmentType	Whole_Brain_Radiation_Therapy
4623804_Patient	treatmentType	Radiotherapy_To_Bone
5623804_Patient	hasGender	Female
5623804_Patient	hasAgeCategory	Young
5623804_Patient	hasStage	IVB
5623804_Patient	hasSmokingHabit	CurrentSmoker
5623804_Patient	hasBiomarker	PDL1_Positive
5623804_Patient	hasBiomarker	ALK_Negative
5623804_Patient	hasBiomarker	EGFR_Negative
5623804_Patient	hasBiomarker	ROS1_Negative
5623804_Patient	hasRelapse_Progression	Progression
5623804_Patient	patientDrug	Atezolizumab
5623804_Patient	patientDrug	Pemetrexed
5623804_Patient	patientDrug	Cisplatin
5623804_Patient	patientDrug	Vinorelbine
5623804_Patient	patientDrug	Docetaxel
5623804_Patient	treatmentType	Intravenous_Chemotherapy
5623804_Patient	treatmentType	Immunotherapy
5623804_Patient	treatmentType	Whole_Brain_Radiation_Therapy
5623804_Patient	treatmentType	Radiotherapy_To_Bone
0810098_Patient	hasGender	Female
0810098_Patient	hasAgeCategory	Young
0810098_Patient	hasStage	IIIA
0810098_Patient	hasSmokingHabit	FormerSmoker
0810098_Patient	hasBiomarker	EGFR_Positive
0810098_Patient	hasRelapse_Progression	Progression
0810098_Patient	patientDrug	Carboplatin
0810098_Patient	patientDrug	Atezolizumab
0810098_Patient	patientDrug	Pemetrexed
0810098_Patient	patientDrug	Vinorelbine
0810098_Patient	patientDrug	Other
0810098_Patient	patientDrug	Docetaxel
0810098_Patient	treatmentType	Intravenous_Chemotherapy
0810098_Patient	treatmentType	Chemotherapy_Adjuvant
0810098_Patient	treatmentType	Molecular_Targeted_Therapy
0810098_Patient	treatmentType	Concurrent_Chemoradiotherapy
0810098_Patient	treatmentType	Immunotherapy
0810098_Patient	treatmentType	Radiotherapy_To_Lung
0810098_Patient	treatmentType	Whole_Brain_Radiation_Therapy
0810098_Patient	treatmentType	Open_Surgical_Procedure
1810098_Patient	hasGender	Female
1810098_Patient	hasAgeCategory	Young
1810098_Patient	hasStage	IIIA
1810098_Patient	hasSmokingHabit	FormerSmoker
1810098_Patient	hasBiomarker	EGFR_Positive
1810098_Patient	hasRelapse_Progression	Progression
1810098_Patient	patientDrug	Carboplatin
1810098_Patient	patientDrug	Atezolizumab
1810098_Patient	patientDrug	Pemetrexed
1810098_Patient	patientDrug	Vinorelbine
1810098_Patient	patientDrug	Other
1810098_Patient	patientDrug	Docetaxel
1810098_Patient	treatmentType	Intravenous_Chemotherapy
1810098_Patient	treatmentType	Chemotherapy_Adjuvant
1810098_Patient	treatmentType	Molecular_Targeted_Therapy
1810098_Patient	treatmentType	Concurrent_Chemoradiotherapy
1810098_Patient	treatmentType	Immunotherapy
1810098_Patient	treatmentType	Radiotherapy_To_Lung
1810098_Patient	treatmentType	Whole_Brain_Radiation_Therapy
1810098_Patient	treatmentType	Open_Surgical_Procedure
2810098_Patient	hasGender	Female
2810098_Patient	hasAgeCategory	Young
2810098_Patient	hasStage	IIIA
2810098_Patient	hasSmokingHabit	FormerSmoker
2810098_Patient	hasBiomarker	EGFR_Positive
2810098_Patient	hasRelapse_Progression	Progression
2810098_Patient	patientDrug	Carboplatin
2810098_Patient	patientDrug	Atezolizumab
2810098_Patient	patientDrug	Pemetrexed
2810098_Patient	patientDrug	Vinorelbine
2810098_Patient	patientDrug	Other
2810098_Patient	patientDrug	Docetaxel
2810098_Patient	treatmentType	Intravenous_Chemotherapy
2810098_Patient	treatmentType	Chemotherapy_Adjuvant
2810098_Patient	treatmentType	Molecular_Targeted_Therapy
2810098_Patient	treatmentType	Concurrent_Chemoradiotherapy
2810098_Patient	treatmentType	Immunotherapy
2810098_Patient	treatmentType	Radiotherapy_To_Lung
2810098_Patient	treatmentType	Whole_Brain_Radiation_Therapy
2810098_Patient	treatmentType	Open_Surgical_Procedure
3810098_Patient	hasGender	Female
3810098_Patient	hasAgeCategory	Young
3810098_Patient	hasStage	IIIA
3810098_Patient	hasSmokingHabit	FormerSmoker
3810098_Patient	hasBiomarker	EGFR_Positive
3810098_Patient	hasRelapse_Progression	Progression
3810098_Patient	patientDrug	Carboplatin
3810098_Patient	patientDrug	Atezolizumab
3810098_Patient	patientDrug	Pemetrexed
3810098_Patient	patientDrug	Vinorelbine
3810098_Patient	patientDrug	Other
3810098_Patient	patientDrug	Docetaxel
3810098_Patient	treatmentType	Intravenous_Chemotherapy
3810098_Patient	treatmentType	Chemotherapy_Adjuvant
3810098_Patient	treatmentType	Molecular_Targeted_Therapy
3810098_Patient	treatmentType	Concurrent_Chemoradiotherapy
3810098_Patient	treatmentType	Immunotherapy
3810098_Patient	treatmentType	Radiotherapy_To_Lung
3810098_Patient	treatmentType	Whole_Brain_Radiation_Therapy
3810098_Patient	treatmentType	Open_Surgical_Procedure
4810098_Patient	hasGender	Female
4810098_Patient	hasAgeCategory	Young
4810098_Patient	hasStage	IIIA
4810098_Patient	hasSmokingHabit	FormerSmoker
4810098_Patient	hasBiomarker	EGFR_Positive
4810098_Patient	hasRelapse_Progression	Progression
4810098_Patient	patientDrug	Carboplatin
4810098_Patient	patientDrug	Atezolizumab
4810098_Patient	patientDrug	Pemetrexed
4810098_Patient	patientDrug	Vinorelbine
4810098_Patient	patientDrug	Other
4810098_Patient	patientDrug	Docetaxel
4810098_Patient	treatmentType	Intravenous_Chemotherapy
4810098_Patient	treatmentType	Chemotherapy_Adjuvant
4810098_Patient	treatmentType	Molecular_Targeted_Therapy
4810098_Patient	treatmentType	Concurrent_Chemoradiotherapy
4810098_Patient	treatmentType	Immunotherapy
4810098_Patient	treatmentType	Radiotherapy_To_Lung
4810098_Patient	treatmentType	Whole_Brain_Radiation_Therapy
4810098_Patient	treatmentType	Open_Surgical_Procedure
5810098_Patient	hasGender	Female
5810098_Patient	hasAgeCategory	Young
5810098_Patient	hasStage	IIIA
5810098_Patient	hasSmokingHabit	FormerSmoker
5810098_Patient	hasBiomarker	EGFR_Positive
5810098_Patient	hasRelapse_Progression	Progression
5810098_Patient	patientDrug	Carboplatin
5810098_Patient	patientDrug	Atezolizumab
5810098_Patient	patientDrug	Pemetrexed
5810098_Patient	patientDrug	Vinorelbine
5810098_Patient	patientDrug	Other
5810098_Patient	patientDrug	Docetaxel
5810098_Patient	treatmentType	Intravenous_Chemotherapy
5810098_Patient	treatmentType	Chemotherapy_Adjuvant
5810098_Patient	treatmentType	Molecular_Targeted_Therapy
5810098_Patient	treatmentType	Concurrent_Chemoradiotherapy
5810098_Patient	treatmentType	Immunotherapy
5810098_Patient	treatmentType	Radiotherapy_To_Lung
5810098_Patient	treatmentType	Whole_Brain_Radiation_Therapy
5810098_Patient	treatmentType	Open_Surgical_Procedure
0829640_Patient	hasGender	Female
0829640_Patient	hasAgeCategory	Young
0829640_Patient	hasStage	IVA
0829640_Patient	hasSmokingHabit	CurrentSmoker
0829640_Patient	hasBiomarker	EGFR_Positive
0829640_Patient	hasBiomarker	PDL1_Positive
0829640_Patient	hasBiomarker	ALK_Negative
0829640_Patient	hasBiomarker	ROS1_Negative
0829640_Patient	hasRelapse_Progression	Progression
0829640_Patient	patientDrug	Carboplatin
0829640_Patient	patientDrug	Pemetrexed
0829640_Patient	patientDrug	Pembrolizumab
0829640_Patient	patientDrug	Docetaxel
0829640_Patient	treatmentType	Intravenous_Chemotherapy
0829640_Patient	treatmentType	Immunotherapy
0829640_Patient	treatmentType	Radiotherapy_To_Lung
1829640_Patient	hasGender	Female
1829640_Patient	hasAgeCategory	Young
1829640_Patient	hasStage	IVA
1829640_Patient	hasSmokingHabit	CurrentSmoker
1829640_Patient	hasBiomarker	EGFR_Positive
1829640_Patient	hasBiomarker	PDL1_Positive
1829640_Patient	hasBiomarker	ALK_Negative
1829640_Patient	hasBiomarker	ROS1_Negative
1829640_Patient	hasRelapse_Progression	Progression
1829640_Patient	patientDrug	Carboplatin
1829640_Patient	patientDrug	Pemetrexed
1829640_Patient	patientDrug	Pembrolizumab
1829640_Patient	patientDrug	Docetaxel
1829640_Patient	treatmentType	Intravenous_Chemotherapy
1829640_Patient	treatmentType	Immunotherapy
1829640_Patient	treatmentType	Radiotherapy_To_Lung
2829640_Patient	hasGender	Female
2829640_Patient	hasAgeCategory	Young
2829640_Patient	hasStage	IVA
2829640_Patient	hasSmokingHabit	CurrentSmoker
2829640_Patient	hasBiomarker	EGFR_Positive
2829640_Patient	hasBiomarker	PDL1_Positive
2829640_Patient	hasBiomarker	ALK_Negative
2829640_Patient	hasBiomarker	ROS1_Negative
2829640_Patient	hasRelapse_Progression	Progression
2829640_Patient	patientDrug	Carboplatin
2829640_Patient	patientDrug	Pemetrexed
2829640_Patient	patientDrug	Pembrolizumab
2829640_Patient	patientDrug	Docetaxel
2829640_Patient	treatmentType	Intravenous_Chemotherapy
2829640_Patient	treatmentType	Immunotherapy
2829640_Patient	treatmentType	Radiotherapy_To_Lung
3829640_Patient	hasGender	Female
3829640_Patient	hasAgeCategory	Young
3829640_Patient	hasStage	IVA
3829640_Patient	hasSmokingHabit	CurrentSmoker
3829640_Patient	hasBiomarker	EGFR_Positive
3829640_Patient	hasBiomarker	PDL1_Positive
3829640_Patient	hasBiomarker	ALK_Negative
3829640_Patient	hasBiomarker	ROS1_Negative
3829640_Patient	hasRelapse_Progression	Progression
3829640_Patient	patientDrug	Carboplatin
3829640_Patient	patientDrug	Pemetrexed
3829640_Patient	patientDrug	Pembrolizumab
3829640_Patient	patientDrug	Docetaxel
3829640_Patient	treatmentType	Intravenous_Chemotherapy
3829640_Patient	treatmentType	Immunotherapy
3829640_Patient	treatmentType	Radiotherapy_To_Lung
4829640_Patient	hasGender	Female
4829640_Patient	hasAgeCategory	Young
4829640_Patient	hasStage	IVA
4829640_Patient	hasSmokingHabit	CurrentSmoker
4829640_Patient	hasBiomarker	EGFR_Positive
4829640_Patient	hasBiomarker	PDL1_Positive
4829640_Patient	hasBiomarker	ALK_Negative
4829640_Patient	hasBiomarker	ROS1_Negative
4829640_Patient	hasRelapse_Progression	Progression
4829640_Patient	patientDrug	Carboplatin
4829640_Patient	patientDrug	Pemetrexed
4829640_Patient	patientDrug	Pembrolizumab
4829640_Patient	patientDrug	Docetaxel
4829640_Patient	treatmentType	Intravenous_Chemotherapy
4829640_Patient	treatmentType	Immunotherapy
4829640_Patient	treatmentType	Radiotherapy_To_Lung
5829640_Patient	hasGender	Female
5829640_Patient	hasAgeCategory	Young
5829640_Patient	hasStage	IVA
5829640_Patient	hasSmokingHabit	CurrentSmoker
5829640_Patient	hasBiomarker	EGFR_Positive
5829640_Patient	hasBiomarker	PDL1_Positive
5829640_Patient	hasBiomarker	ALK_Negative
5829640_Patient	hasBiomarker	ROS1_Negative
5829640_Patient	hasRelapse_Progression	Progression
5829640_Patient	patientDrug	Carboplatin
5829640_Patient	patientDrug	Pemetrexed
5829640_Patient	patientDrug	Pembrolizumab
5829640_Patient	patientDrug	Docetaxel
5829640_Patient	treatmentType	Intravenous_Chemotherapy
5829640_Patient	treatmentType	Immunotherapy
5829640_Patient	treatmentType	Radiotherapy_To_Lung
0790159_Patient	hasGender	Male
0790159_Patient	hasAgeCategory	Old
0790159_Patient	hasStage	IVA
0790159_Patient	hasSmokingHabit	FormerSmoker
0790159_Patient	hasBiomarker	PDL1_Positive
0790159_Patient	hasRelapse_Progression	Progression
0790159_Patient	patientDrug	Pembrolizumab
0790159_Patient	patientDrug	Afatinib
0790159_Patient	treatmentType	Immunotherapy
0790159_Patient	treatmentType	Radiotherapy_To_Lung
1790159_Patient	hasGender	Male
1790159_Patient	hasAgeCategory	Old
1790159_Patient	hasStage	IVA
1790159_Patient	hasSmokingHabit	FormerSmoker
1790159_Patient	hasBiomarker	PDL1_Positive
1790159_Patient	hasRelapse_Progression	Progression
1790159_Patient	patientDrug	Pembrolizumab
1790159_Patient	patientDrug	Afatinib
1790159_Patient	treatmentType	Immunotherapy
1790159_Patient	treatmentType	Radiotherapy_To_Lung
2790159_Patient	hasGender	Male
2790159_Patient	hasAgeCategory	Old
2790159_Patient	hasStage	IVA
2790159_Patient	hasSmokingHabit	FormerSmoker
2790159_Patient	hasBiomarker	PDL1_Positive
2790159_Patient	hasRelapse_Progression	Progression
2790159_Patient	patientDrug	Pembrolizumab
2790159_Patient	patientDrug	Afatinib
2790159_Patient	treatmentType	Immunotherapy
2790159_Patient	treatmentType	Radiotherapy_To_Lung
3790159_Patient	hasGender	Male
3790159_Patient	hasAgeCategory	Old
3790159_Patient	hasStage	IVA
3790159_Patient	hasSmokingHabit	FormerSmoker
3790159_Patient	hasBiomarker	PDL1_Positive
3790159_Patient	hasRelapse_Progression	Progression
3790159_Patient	patientDrug	Pembrolizumab
3790159_Patient	patientDrug	Afatinib
3790159_Patient	treatmentType	Immunotherapy
3790159_Patient	treatmentType	Radiotherapy_To_Lung
4790159_Patient	hasGender	Male
4790159_Patient	hasAgeCategory	Old
4790159_Patient	hasStage	IVA
4790159_Patient	hasSmokingHabit	FormerSmoker
4790159_Patient	hasBiomarker	PDL1_Positive
4790159_Patient	hasRelapse_Progression	Progression
4790159_Patient	patientDrug	Pembrolizumab
4790159_Patient	patientDrug	Afatinib
4790159_Patient	treatmentType	Immunotherapy
4790159_Patient	treatmentType	Radiotherapy_To_Lung
5790159_Patient	hasGender	Male
5790159_Patient	hasAgeCategory	Old
5790159_Patient	hasStage	IVA
5790159_Patient	hasSmokingHabit	FormerSmoker
5790159_Patient	hasBiomarker	PDL1_Positive
5790159_Patient	hasRelapse_Progression	Progression
5790159_Patient	patientDrug	Pembrolizumab
5790159_Patient	patientDrug	Afatinib
5790159_Patient	treatmentType	Immunotherapy
5790159_Patient	treatmentType	Radiotherapy_To_Lung
01110078_Patient	hasGender	Male
01110078_Patient	hasAgeCategory	Young
01110078_Patient	hasStage	IVB
01110078_Patient	hasSmokingHabit	CurrentSmoker
01110078_Patient	hasBiomarker	EGFR_Positive
01110078_Patient	hasBiomarker	ALK_Negative
01110078_Patient	hasRelapse_Progression	Progression
01110078_Patient	patientDrug	Carboplatin
01110078_Patient	patientDrug	Paclitaxel
01110078_Patient	patientDrug	Pemetrexed
01110078_Patient	patientDrug	Cisplatin
01110078_Patient	patientDrug	Afatinib
01110078_Patient	patientDrug	Osimertinib
01110078_Patient	treatmentType	Intravenous_Chemotherapy
01110078_Patient	treatmentType	Molecular_Targeted_Therapy
01110078_Patient	treatmentType	Radiotherapy_To_Bone
11110078_Patient	hasGender	Male
11110078_Patient	hasAgeCategory	Young
11110078_Patient	hasStage	IVB
11110078_Patient	hasSmokingHabit	CurrentSmoker
11110078_Patient	hasBiomarker	EGFR_Positive
11110078_Patient	hasBiomarker	ALK_Negative
11110078_Patient	hasRelapse_Progression	Progression
11110078_Patient	patientDrug	Carboplatin
11110078_Patient	patientDrug	Paclitaxel
11110078_Patient	patientDrug	Pemetrexed
11110078_Patient	patientDrug	Cisplatin
11110078_Patient	patientDrug	Afatinib
11110078_Patient	patientDrug	Osimertinib
11110078_Patient	treatmentType	Intravenous_Chemotherapy
11110078_Patient	treatmentType	Molecular_Targeted_Therapy
11110078_Patient	treatmentType	Radiotherapy_To_Bone
21110078_Patient	hasGender	Male
21110078_Patient	hasAgeCategory	Young
21110078_Patient	hasStage	IVB
21110078_Patient	hasSmokingHabit	CurrentSmoker
21110078_Patient	hasBiomarker	EGFR_Positive
21110078_Patient	hasBiomarker	ALK_Negative
21110078_Patient	hasRelapse_Progression	Progression
21110078_Patient	patientDrug	Carboplatin
21110078_Patient	patientDrug	Paclitaxel
21110078_Patient	patientDrug	Pemetrexed
21110078_Patient	patientDrug	Cisplatin
21110078_Patient	patientDrug	Afatinib
21110078_Patient	patientDrug	Osimertinib
21110078_Patient	treatmentType	Intravenous_Chemotherapy
21110078_Patient	treatmentType	Molecular_Targeted_Therapy
21110078_Patient	treatmentType	Radiotherapy_To_Bone
31110078_Patient	hasGender	Male
31110078_Patient	hasAgeCategory	Young
31110078_Patient	hasStage	IVB
31110078_Patient	hasSmokingHabit	CurrentSmoker
31110078_Patient	hasBiomarker	EGFR_Positive
31110078_Patient	hasBiomarker	ALK_Negative
31110078_Patient	hasRelapse_Progression	Progression
31110078_Patient	patientDrug	Carboplatin
31110078_Patient	patientDrug	Paclitaxel
31110078_Patient	patientDrug	Pemetrexed
31110078_Patient	patientDrug	Cisplatin
31110078_Patient	patientDrug	Afatinib
31110078_Patient	patientDrug	Osimertinib
31110078_Patient	treatmentType	Intravenous_Chemotherapy
31110078_Patient	treatmentType	Molecular_Targeted_Therapy
31110078_Patient	treatmentType	Radiotherapy_To_Bone
41110078_Patient	hasGender	Male
41110078_Patient	hasAgeCategory	Young
41110078_Patient	hasStage	IVB
41110078_Patient	hasSmokingHabit	CurrentSmoker
41110078_Patient	hasBiomarker	EGFR_Positive
41110078_Patient	hasBiomarker	ALK_Negative
41110078_Patient	hasRelapse_Progression	Progression
41110078_Patient	patientDrug	Carboplatin
41110078_Patient	patientDrug	Paclitaxel
41110078_Patient	patientDrug	Pemetrexed
41110078_Patient	patientDrug	Cisplatin
41110078_Patient	patientDrug	Afatinib
41110078_Patient	patientDrug	Osimertinib
41110078_Patient	treatmentType	Intravenous_Chemotherapy
41110078_Patient	treatmentType	Molecular_Targeted_Therapy
41110078_Patient	treatmentType	Radiotherapy_To_Bone
51110078_Patient	hasGender	Male
51110078_Patient	hasAgeCategory	Young
51110078_Patient	hasStage	IVB
51110078_Patient	hasSmokingHabit	CurrentSmoker
51110078_Patient	hasBiomarker	EGFR_Positive
51110078_Patient	hasBiomarker	ALK_Negative
51110078_Patient	hasRelapse_Progression	Progression
51110078_Patient	patientDrug	Carboplatin
51110078_Patient	patientDrug	Paclitaxel
51110078_Patient	patientDrug	Pemetrexed
51110078_Patient	patientDrug	Cisplatin
51110078_Patient	patientDrug	Afatinib
51110078_Patient	patientDrug	Osimertinib
51110078_Patient	treatmentType	Intravenous_Chemotherapy
51110078_Patient	treatmentType	Molecular_Targeted_Therapy
51110078_Patient	treatmentType	Radiotherapy_To_Bone
02831180_Patient	hasGender	Female
02831180_Patient	hasAgeCategory	Young
02831180_Patient	hasStage	IVB
02831180_Patient	hasSmokingHabit	NonSmoker
02831180_Patient	hasBiomarker	EGFR_Positive
02831180_Patient	hasBiomarker	PDL1_Positive
02831180_Patient	hasBiomarker	ALK_Negative
02831180_Patient	hasBiomarker	ROS1_Negative
02831180_Patient	patientDrug	Afatinib
02831180_Patient	patientDrug	Osimertinib
02831180_Patient	treatmentType	Molecular_Targeted_Therapy
02831180_Patient	treatmentType	Radiotherapy_To_Bone
12831180_Patient	hasGender	Female
12831180_Patient	hasAgeCategory	Young
12831180_Patient	hasStage	IVB
12831180_Patient	hasSmokingHabit	NonSmoker
12831180_Patient	hasBiomarker	EGFR_Positive
12831180_Patient	hasBiomarker	PDL1_Positive
12831180_Patient	hasBiomarker	ALK_Negative
12831180_Patient	hasBiomarker	ROS1_Negative
12831180_Patient	patientDrug	Afatinib
12831180_Patient	patientDrug	Osimertinib
12831180_Patient	treatmentType	Molecular_Targeted_Therapy
12831180_Patient	treatmentType	Radiotherapy_To_Bone
22831180_Patient	hasGender	Female
22831180_Patient	hasAgeCategory	Young
22831180_Patient	hasStage	IVB
22831180_Patient	hasSmokingHabit	NonSmoker
22831180_Patient	hasBiomarker	EGFR_Positive
22831180_Patient	hasBiomarker	PDL1_Positive
22831180_Patient	hasBiomarker	ALK_Negative
22831180_Patient	hasBiomarker	ROS1_Negative
22831180_Patient	patientDrug	Afatinib
22831180_Patient	patientDrug	Osimertinib
22831180_Patient	treatmentType	Molecular_Targeted_Therapy
22831180_Patient	treatmentType	Radiotherapy_To_Bone
32831180_Patient	hasGender	Female
32831180_Patient	hasAgeCategory	Young
32831180_Patient	hasStage	IVB
32831180_Patient	hasSmokingHabit	NonSmoker
32831180_Patient	hasBiomarker	EGFR_Positive
32831180_Patient	hasBiomarker	PDL1_Positive
32831180_Patient	hasBiomarker	ALK_Negative
32831180_Patient	hasBiomarker	ROS1_Negative
32831180_Patient	patientDrug	Afatinib
32831180_Patient	patientDrug	Osimertinib
32831180_Patient	treatmentType	Molecular_Targeted_Therapy
32831180_Patient	treatmentType	Radiotherapy_To_Bone
42831180_Patient	hasGender	Female
42831180_Patient	hasAgeCategory	Young
42831180_Patient	hasStage	IVB
42831180_Patient	hasSmokingHabit	NonSmoker
42831180_Patient	hasBiomarker	EGFR_Positive
42831180_Patient	hasBiomarker	PDL1_Positive
42831180_Patient	hasBiomarker	ALK_Negative
42831180_Patient	hasBiomarker	ROS1_Negative
42831180_Patient	patientDrug	Afatinib
42831180_Patient	patientDrug	Osimertinib
42831180_Patient	treatmentType	Molecular_Targeted_Therapy
42831180_Patient	treatmentType	Radiotherapy_To_Bone
52831180_Patient	hasGender	Female
52831180_Patient	hasAgeCategory	Young
52831180_Patient	hasStage	IVB
52831180_Patient	hasSmokingHabit	NonSmoker
52831180_Patient	hasBiomarker	EGFR_Positive
52831180_Patient	hasBiomarker	PDL1_Positive
52831180_Patient	hasBiomarker	ALK_Negative
52831180_Patient	hasBiomarker	ROS1_Negative
52831180_Patient	patientDrug	Afatinib
52831180_Patient	patientDrug	Osimertinib
52831180_Patient	treatmentType	Molecular_Targeted_Therapy
52831180_Patient	treatmentType	Radiotherapy_To_Bone
0583557_Patient	hasGender	Male
0583557_Patient	hasAgeCategory	Old
0583557_Patient	hasStage	IVB
0583557_Patient	hasSmokingHabit	NonSmoker
0583557_Patient	hasBiomarker	EGFR_Positive
0583557_Patient	hasBiomarker	ALK_Negative
0583557_Patient	hasBiomarker	ROS1_Negative
0583557_Patient	hasRelapse_Progression	Progression
0583557_Patient	patientDrug	Carboplatin
0583557_Patient	patientDrug	Pemetrexed
0583557_Patient	patientDrug	Vinorelbine
0583557_Patient	patientDrug	Erlotinib
0583557_Patient	patientDrug	Gefitinib
0583557_Patient	treatmentType	Molecular_Targeted_Therapy
0583557_Patient	treatmentType	Immunotherapy
0583557_Patient	treatmentType	Radiotherapy_To_Bone
0583557_Patient	hasBiomarker	EGFR_Negative
1583557_Patient	hasGender	Male
1583557_Patient	hasAgeCategory	Old
1583557_Patient	hasStage	IVB
1583557_Patient	hasSmokingHabit	NonSmoker
1583557_Patient	hasBiomarker	EGFR_Positive
1583557_Patient	hasBiomarker	ALK_Negative
1583557_Patient	hasBiomarker	ROS1_Negative
1583557_Patient	hasRelapse_Progression	Progression
1583557_Patient	patientDrug	Carboplatin
1583557_Patient	patientDrug	Pemetrexed
1583557_Patient	patientDrug	Vinorelbine
1583557_Patient	patientDrug	Erlotinib
1583557_Patient	patientDrug	Gefitinib
1583557_Patient	treatmentType	Molecular_Targeted_Therapy
1583557_Patient	treatmentType	Immunotherapy
1583557_Patient	treatmentType	Radiotherapy_To_Bone
1583557_Patient	hasBiomarker	EGFR_Negative
2583557_Patient	hasGender	Male
2583557_Patient	hasAgeCategory	Old
2583557_Patient	hasStage	IVB
2583557_Patient	hasSmokingHabit	NonSmoker
2583557_Patient	hasBiomarker	EGFR_Positive
2583557_Patient	hasBiomarker	ALK_Negative
2583557_Patient	hasBiomarker	ROS1_Negative
2583557_Patient	hasRelapse_Progression	Progression
2583557_Patient	patientDrug	Carboplatin
2583557_Patient	patientDrug	Pemetrexed
2583557_Patient	patientDrug	Vinorelbine
2583557_Patient	patientDrug	Erlotinib
2583557_Patient	patientDrug	Gefitinib
2583557_Patient	treatmentType	Molecular_Targeted_Therapy
2583557_Patient	treatmentType	Immunotherapy
2583557_Patient	treatmentType	Radiotherapy_To_Bone
2583557_Patient	hasBiomarker	EGFR_Negative
3583557_Patient	hasGender	Male
3583557_Patient	hasAgeCategory	Old
3583557_Patient	hasStage	IVB
3583557_Patient	hasSmokingHabit	NonSmoker
3583557_Patient	hasBiomarker	EGFR_Positive
3583557_Patient	hasBiomarker	ALK_Negative
3583557_Patient	hasBiomarker	ROS1_Negative
3583557_Patient	hasRelapse_Progression	Progression
3583557_Patient	patientDrug	Carboplatin
3583557_Patient	patientDrug	Pemetrexed
3583557_Patient	patientDrug	Vinorelbine
3583557_Patient	patientDrug	Erlotinib
3583557_Patient	patientDrug	Gefitinib
3583557_Patient	treatmentType	Molecular_Targeted_Therapy
3583557_Patient	treatmentType	Immunotherapy
3583557_Patient	treatmentType	Radiotherapy_To_Bone
3583557_Patient	hasBiomarker	EGFR_Negative
4583557_Patient	hasGender	Male
4583557_Patient	hasAgeCategory	Old
4583557_Patient	hasStage	IVB
4583557_Patient	hasSmokingHabit	NonSmoker
4583557_Patient	hasBiomarker	EGFR_Positive
4583557_Patient	hasBiomarker	ALK_Negative
4583557_Patient	hasBiomarker	ROS1_Negative
4583557_Patient	hasRelapse_Progression	Progression
4583557_Patient	patientDrug	Carboplatin
4583557_Patient	patientDrug	Pemetrexed
4583557_Patient	patientDrug	Vinorelbine
4583557_Patient	patientDrug	Erlotinib
4583557_Patient	patientDrug	Gefitinib
4583557_Patient	treatmentType	Molecular_Targeted_Therapy
4583557_Patient	treatmentType	Immunotherapy
4583557_Patient	treatmentType	Radiotherapy_To_Bone
4583557_Patient	hasBiomarker	EGFR_Negative
5583557_Patient	hasGender	Male
5583557_Patient	hasAgeCategory	Old
5583557_Patient	hasStage	IVB
5583557_Patient	hasSmokingHabit	NonSmoker
5583557_Patient	hasBiomarker	EGFR_Positive
5583557_Patient	hasBiomarker	ALK_Negative
5583557_Patient	hasBiomarker	ROS1_Negative
5583557_Patient	hasRelapse_Progression	Progression
5583557_Patient	patientDrug	Carboplatin
5583557_Patient	patientDrug	Pemetrexed
5583557_Patient	patientDrug	Vinorelbine
5583557_Patient	patientDrug	Erlotinib
5583557_Patient	patientDrug	Gefitinib
5583557_Patient	treatmentType	Molecular_Targeted_Therapy
5583557_Patient	treatmentType	Immunotherapy
5583557_Patient	treatmentType	Radiotherapy_To_Bone
5583557_Patient	hasBiomarker	EGFR_Negative
01077426_Patient	hasGender	Female
01077426_Patient	hasAgeCategory	Young
01077426_Patient	hasStage	IVA
01077426_Patient	hasSmokingHabit	FormerSmoker
01077426_Patient	hasBiomarker	EGFR_Positive
01077426_Patient	hasBiomarker	PDL1_Positive
01077426_Patient	hasBiomarker	ALK_Negative
01077426_Patient	hasBiomarker	BRAF_Negative
01077426_Patient	hasBiomarker	ROS1_Negative
01077426_Patient	patientDrug	Osimertinib
01077426_Patient	treatmentType	Molecular_Targeted_Therapy
01077426_Patient	treatmentType	Whole_Brain_Radiation_Therapy
01077426_Patient	treatmentType	Radiotherapy_To_Bone
01077426_Patient	hasBiomarker	EGFR_Negative
11077426_Patient	hasGender	Female
11077426_Patient	hasAgeCategory	Young
11077426_Patient	hasStage	IVA
11077426_Patient	hasSmokingHabit	FormerSmoker
11077426_Patient	hasBiomarker	EGFR_Positive
11077426_Patient	hasBiomarker	PDL1_Positive
11077426_Patient	hasBiomarker	ALK_Negative
11077426_Patient	hasBiomarker	BRAF_Negative
11077426_Patient	hasBiomarker	ROS1_Negative
11077426_Patient	patientDrug	Osimertinib
11077426_Patient	treatmentType	Molecular_Targeted_Therapy
11077426_Patient	treatmentType	Whole_Brain_Radiation_Therapy
11077426_Patient	treatmentType	Radiotherapy_To_Bone
11077426_Patient	hasBiomarker	EGFR_Negative
21077426_Patient	hasGender	Female
21077426_Patient	hasAgeCategory	Young
21077426_Patient	hasStage	IVA
21077426_Patient	hasSmokingHabit	FormerSmoker
21077426_Patient	hasBiomarker	EGFR_Positive
21077426_Patient	hasBiomarker	PDL1_Positive
21077426_Patient	hasBiomarker	ALK_Negative
21077426_Patient	hasBiomarker	BRAF_Negative
21077426_Patient	hasBiomarker	ROS1_Negative
21077426_Patient	patientDrug	Osimertinib
21077426_Patient	treatmentType	Molecular_Targeted_Therapy
21077426_Patient	treatmentType	Whole_Brain_Radiation_Therapy
21077426_Patient	treatmentType	Radiotherapy_To_Bone
21077426_Patient	hasBiomarker	EGFR_Negative
31077426_Patient	hasGender	Female
31077426_Patient	hasAgeCategory	Young
31077426_Patient	hasStage	IVA
31077426_Patient	hasSmokingHabit	FormerSmoker
31077426_Patient	hasBiomarker	EGFR_Positive
31077426_Patient	hasBiomarker	PDL1_Positive
31077426_Patient	hasBiomarker	ALK_Negative
31077426_Patient	hasBiomarker	BRAF_Negative
31077426_Patient	hasBiomarker	ROS1_Negative
31077426_Patient	patientDrug	Osimertinib
31077426_Patient	treatmentType	Molecular_Targeted_Therapy
31077426_Patient	treatmentType	Whole_Brain_Radiation_Therapy
31077426_Patient	treatmentType	Radiotherapy_To_Bone
31077426_Patient	hasBiomarker	EGFR_Negative
41077426_Patient	hasGender	Female
41077426_Patient	hasAgeCategory	Young
41077426_Patient	hasStage	IVA
41077426_Patient	hasSmokingHabit	FormerSmoker
41077426_Patient	hasBiomarker	EGFR_Positive
41077426_Patient	hasBiomarker	PDL1_Positive
41077426_Patient	hasBiomarker	ALK_Negative
41077426_Patient	hasBiomarker	BRAF_Negative
41077426_Patient	hasBiomarker	ROS1_Negative
41077426_Patient	patientDrug	Osimertinib
41077426_Patient	treatmentType	Molecular_Targeted_Therapy
41077426_Patient	treatmentType	Whole_Brain_Radiation_Therapy
41077426_Patient	treatmentType	Radiotherapy_To_Bone
41077426_Patient	hasBiomarker	EGFR_Negative
51077426_Patient	hasGender	Female
51077426_Patient	hasAgeCategory	Young
51077426_Patient	hasStage	IVA
51077426_Patient	hasSmokingHabit	FormerSmoker
51077426_Patient	hasBiomarker	EGFR_Positive
51077426_Patient	hasBiomarker	PDL1_Positive
51077426_Patient	hasBiomarker	ALK_Negative
51077426_Patient	hasBiomarker	BRAF_Negative
51077426_Patient	hasBiomarker	ROS1_Negative
51077426_Patient	patientDrug	Osimertinib
51077426_Patient	treatmentType	Molecular_Targeted_Therapy
51077426_Patient	treatmentType	Whole_Brain_Radiation_Therapy
51077426_Patient	treatmentType	Radiotherapy_To_Bone
51077426_Patient	hasBiomarker	EGFR_Negative
